株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

骨セメントデリバリーサービスの世界市場:2019年~2030年

Bone Cement Delivery Systems Market, 2019-2030

発行 ROOTS ANALYSIS 商品コード 808187
出版日 ページ情報 英文 472 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.06円で換算しております。
Back to Top
骨セメントデリバリーサービスの世界市場:2019年~2030年 Bone Cement Delivery Systems Market, 2019-2030
出版日: 2019年03月31日 ページ情報: 英文 472 Pages
概要

国連の調査によると、世界の高齢者人口 (60歳以上) は、2030年までに13億人に達すると予測されています。それに従い、骨粗しょう症関連の世界的負担は、大幅に増加することが予測されています。

当レポートでは、世界の骨セメントデリバリーサービス市場について調査分析し、現状と将来の見通しについて、体系的な情報を提供しています。

第1章 序文

第2章 エグゼクティブサマリー

第3章 イントロダクション

  • 概要
  • 骨セメントのコンセプト
  • 骨セメントデリバリーシステムの概要
  • 主な応用分野
  • 骨セメントデリバリーシステムの利点と制限
  • 結論

第4章 市場情勢

  • 概要
  • 骨セメントデリバリーシステム:デバイスのリスト
  • 骨セメントデリバリーシステム:デバイス開発業者のリスト
  • 骨セメント混合システムのリスト
  • 結論

第5章 規制情勢

  • 概要
  • 北米の規制ガイドライン
  • 欧州の規制ガイドライン
  • アジア太平洋地域・その他の地域の規制ガイドライン
  • ヒートマップ分析:地域別の取締管理の比較

第6章 企業プロファイル

  • 概要
  • 既存企業のプロファイル
    • DePuy Synthes
    • Medtronic
    • Merit Medical Systems
    • Smith & Nephew
    • Stryker
    • Zimmer Biomet
  • 中小企業のプロファイル
    • Biopsybell
    • iMedicom
    • IZI Medical Products
    • Spirit Spine
    • Synimed

第7章 M&A

  • 概要
  • 買収モデル
  • 骨セメントデリバリーシステム:M&A

第8章 特許分析

第9章 治験分析

第10章 助成金分析

第11章 需要分析

  • 概要
  • 調査範囲・手法
  • 世界の需要
  • 北米の需要
  • 欧州の需要
  • アジア太平洋地域・その他の地域の需要
  • 結論

第12章 市場予測

  • 概要
  • 予測手法と主な前提条件
  • 市場
  • 分布:外科手術のタイプ別
  • 分布:エンドユーザーのタイプ別
  • 分布:地域別
  • 分布:外科手術のタイプ・地域別
  • 分布:エンドユーザー・地域別

第13章 結論

第14章 インタビュー

第15章 付録1

第16章 付録2

目次
Product Code: RA100130

Example Highlights:

These systems are being assessed for diverse orthopaedic procedures across multiple clinical trials: a number of clinical trial end points are under evaluation.

Overview:

“Currently, there seems to be a mixed adoption trend between bone cement based arthroplasty and cement-less hip / knee implants. However, I believe bone cement based arthroplasty surgeries are likely to decrease in the near future owing to the increasing popularity of cement -less surgeries”-- Associate Professor, a Sweden-based University.

According to a study conducted by the International Osteoporosis Foundation (IOF), more than 200 million individuals around the world suffer from osteoporosis. In fact, a total of 8.9 million fractures per year are attributed to osteoporosis, implying that an osteoporotic fracture (of the hip, knee, spine, shoulder, or wrist) occurs after every three seconds. The annual socioeconomic burden associated with this condition is estimated to be around USD 19 billion and EUR 37 billion, in the US and Europe, respectively. Further estimates suggest that, by 2030, nearly 3.5 million knee replacements and 572,000 hip replacements are likely to be performed every year in the US alone. A recent United Nations' study projected the global elderly population (aged 60 years and above) to rise to 1.3 billion by 2030; given the susceptibility of this population segment to developing osteoporosis, the global burden related to this particular disease is anticipated to increase significantly in the foreseen future.

Over time, bone cement delivery systems have become widely popular in diverse types of orthopedic surgeries / procedures. There are many benefits of using such devices, including ease-of-use, targeted and controlled delivery of bone cements, integrated safety mechanisms, and an almost negligible risk of injury to patients. Companies involved in the development / manufacturing of bone cement delivery systems have also captured the interest of several stakeholders / bone cement developers that are looking for novel ways to deliver various types of bone cements to target sites during surgical procedures. In fact, since 2010, over 6,000 patents have been published in this domain, indicating the rapid pace at which research is being carried out. It is anticipated that such efforts are likely to boost the overall growth of this market in the coming years.

Scope of the Report:

The ‘Bone Cement Delivery Systems Market, 2019-2030' report features an extensive study of the current landscape and the likely future evolution of such systems in the next twelve years. The study features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different global regions. Amongst other elements, the report includes:

  • A detailed assessment of the current landscape of bone cement delivery systems market, highlighting the contributions of industry players engaged in this domain, along with key system specifications. It features information on the type of surgical procedures (arthroplasty, kyphoplasty and vertebroplasty), compatibility with different types of bone cements (polymethyl methacrylate, calcium phosphate and others), viscosity of bone cements delivered (high, medium and low), system functionality (delivery and mixing), approval date of various products, and maximum capacity.
  • An elaborate discussion on the various guidelines established by major regulatory bodies for medical device approval, including bone cement delivery systems, across different countries. It also includes an insightful multi-dimensional heat map analysis, featuring a review of the contemporary regulatory scenario in key geographies across the globe.
  • Elaborate profiles of large companies offering bone cement delivery systems (shortlisted on the basis of the number of systems), featuring an overview of the company, its financial information (if available), detailed descriptions of their bone cement delivery systems, and a comprehensive future outlook. In addition, the chapter features tabulated profiles of small-sized and mid-sized bone cement delivery system providers (shortlisted on the basis of number of systems), featuring details on company headquarters, year of establishment, number of employees, executive team, recent developments, along with detailed descriptions of their proprietary bone cement delivery systems.
  • A detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2014-2018, based on parameters, such as year of acquisition, type of acquisition, geographical location of the acquirer and the acquired company, key value drivers, and financial details of the deal (if available). The analysis also features an ownership change matrix, providing insights on the involvement of private and public sector entities in this domain. In addition, the chapter evaluates the deal multiples of acquisitions specifically focused on bone cement delivery systems, analyzing them based on a number of parameters, namely annual revenues, number of employees and the experience of the acquired company. Moreover, it presents a schematic world map representation of the geographical distribution of this activity, highlighting inter- and intracontinental deals.
  • An in-depth analysis of the various patents that have been filed / granted related to bone cement delivery systems since 1976. The analysis also highlights the key parameters associated with the patents, including information on patent type (granted patents, patent applications and others), publication year, CPC classification, emerging focus areas (in terms of number of patents filed / granted), type of surgical procedures (arthroplasty, kyphoplasty and vertebroplasty), industry type and leading industry / non-industry players (in terms of size of intellectual property portfolio). It also features a valuation analysis taking into consideration older patents, which have expired, highlighting the upcoming opportunity for generic product developers and manufacturers in this domain.
  • A comprehensive clinical trial analysis of completed, ongoing and planned studies of different types of bone cements and associated delivery systems for various surgical procedures. For the purpose of this analysis, we considered the clinical studies that started in 1997, and analyzed them on the basis of various parameters, such as trial registration year, current trial status, current trial phase, study design, type of surgical procedure, study focus, leading industry and non-industry players, regional distribution, and enrolled patient population across different geographies. In addition, it features an insightful clinical end-points analysis of ongoing and planned studies.
  • A detailed study on the various grants that have been awarded to research institutes conducting projects related to different types of bone cements, between 2010 and 2018. The analysis highlights various important parameters associated with grants, such as year of award, support period, amount awarded, type of surgical procedures, grant type, responsible study section, focus area and type of bone cements.
  • An analysis to estimate the likely demand for bone cement delivery systems across key surgical procedures, including kyphoplasty, vertebroplasty, hip arthroplasty and knee arthroplasty, in different global regions for the period 2019-2030.

One of the key objectives of the report was to estimate the existing market size and potential growth opportunities for bone cement delivery systems over the coming decade. Based on several parameters, such as prices of systems, surgical procedure / region specific adoption trends, and competitive landscape, we have provided an informed estimate on the likely evolution of the market, over the period 2019-2030. The report provides sales forecasts for the overall bone cement delivery systems market with the current and upcoming opportunity segmented across [A] surgical procedure(s) (hip arthroplasty, knee arthroplasty, kyphoplasty and vertebroplasty), [B] type of end-user(s) (ambulatory surgery centers, hospitals and specialty clinics), and [C] key geographies (North America (the US, Canada and Mexico), Europe (EU5 countries), Asia-Pacific and Rest of the World (Australia, China, India, and Japan)). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry's growth.

The opinions and insights presented in this study were also influenced by discussions conducted with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals (in alphabetical order of organization names):

  • Soren Toksvig-Larsen (Associate Professor, Department of Orthopedics, Lund University)
  • John Williams (Director of Musculoskeletal and Renal Biology Programs, Division of Aging Biology, National Institutes of Health)
  • Francesco De Paola (International Product Manager, Medacta International)
  • Ana Bettencourt (Associate Professor, University of Lisbon)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Contents:

Chapter 2 provides an executive summary of the insights captured in our research. It offers a high-level view on the present state of the bone cement delivery systems market and its likely evolution in the short-mid and long terms.

Chapter 3 provides a general introduction to the various types of bone cements, including a comprehensive overview of the evolution of such materials, their basic composition, and classification. It also includes an elaborate discussion on the different parameters that impact the physiochemical properties of different types of bone cements. The chapter lays emphasis on the types of bone cement delivery systems, listing their distinguishing features. Subsequently, it provides an overview of the key surgical procedures, including vertebroplasty, kyphoplasty and arthroplasty, for bone cements and affiliated delivery technologies. It also features a brief discussion on the various advantages and limitations related to the use of bone cement delivery systems.

Chapter 4 presents a list of more than 70 delivery systems designed for the administration of bone cements across various types of orthopedic surgeries / procedures. It includes a detailed analysis of the aforementioned products based on the type of surgical procedures (arthroplasty, kyphoplasty and vertebroplasty), compatibility with different types of bone cements (polymethyl methacrylate, calcium phosphate and others), viscosity of bone cements delivered (high, medium and low), system functionality (delivery and mixing), approval date of various products, and maximum capacity. It also provides details of the developer companies, such as year of establishment, company size and location of headquarters.In addition, the chapter features an indicative list of bone cement mixing device providers.

Chapter 5 features a detailed discussion on the various guidelines established by major regulatory bodies, for the evaluation and approval of medical devices, including bone cement delivery systems, across different countries. It also includes an insightful heat map analysis, featuring a review of the contemporary regulatory scenario in key geographies across the globe.

Chapter 6 features detailed profiles of large companies offering bone cement delivery systems (shortlisted on the basis of systems). Each company profile includes a brief overview of the company, financial information (if available), detailed descriptions of their bone cement delivery systems, and a comprehensive future outlook. In addition, the chapter includes tabulated profiles of small-sized and mid-sized bone cement delivery system providers (shortlisted on the basis of number of systems), providing details on company headquarters, year of establishment, number of employees, executive team, recent developments, along with detailed descriptions of their proprietary bone cement delivery systems.

Chapter 7 features a detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2014-2018, based on parameters, such as key value drivers, year of acquisition, type of acquisition, geographical location of the acquirer and the acquired company, and financial details of the deal (if available). The analysis also features an ownership change matrix, providing insights on the involvement of private and public sector entities in this domain. In addition, the chapter evaluates the deal multiples of acquisitions specifically focused on bone cement delivery systems, analyzing them based on a number of parameters, namely annual revenues, number of employees and the experience of the acquired company. Moreover, it presents a schematic world map representation of the geographical distribution of this activity, highlighting inter- and intracontinental deals.

Chapter 8 provides insights from a detailed patent analysis, presenting an overview on the filed / granted patents related to bone cement delivery systems since 1976. For this analysis, we looked at the patents that have been published by various players till November 2018. It also highlights the important information and key trends associated with these patents, including patent type (granted patents, patent applications and others), publication year, CPC classification, emerging focus areas (in terms of number of patents filed / granted) , type of surgical procedures (arthroplasty, kyphoplasty and vertebroplasty), patent issuing regions, industry type and leading industry / non-industry players (in terms of size of intellectual property portfolio) . The chapter also features a valuation analysis taking into consideration older patents, which have expired, highlighting the upcoming opportunity for generic product developers and manufacturers in this domain.

Chapter 9 presents a comprehensive clinical trial analysis of the completed, ongoing and planned studies related to different types of bone cements and associated delivery systems for various surgical procedures. For the purpose of this analysis, we looked at the clinical studies of bone cements and affiliated delivery systems which started in 1997, and analyzed them on the basis of various parameters, such as trial registration year, current trial status, current trial phase, study design, type of surgical procedure, study focus, leading industry and non-industry players, regional distribution, and enrolled patient population across different geographies. In addition, it features an insightful analysis of key clinical end-points of ongoing and planned studies.

Chapter 10 provides information on the various grants that were awarded to research institutes conducting projects related to different types of bone cements, between 2010 and 2018. The analysis also highlights important parameters associated with grants, such as year of award, support period, amount awarded, type of surgical procedures, grant type, responsible study section, focus area, and type of bone cements.

Chapter 11 providesan overview of the demand for bone cement delivery systems across key surgical procedures, including kyphoplasty, vertebroplasty, hip arthroplasty and knee arthroplasty, in the contemporary market. In order to estimate the aforementioned demand, we considered the number of osteoporosis related fractures reported across different geographies, and the subsequent cemented orthopedic procedures used for treatment, which is indicative of the demand. We have also estimated the likely adoption of such products across key surgical procedures, over the period 2019-2030.

Chapter 12 features a comprehensive market forecast, highlighting the future potential of bone cement delivery systems market till 2030, based on multiple parameters, such as prices of systems, surgical procedure / region specific adoption trends, and competitive landscape. We have segregated the current and upcoming opportunity on the basis of [A] surgical procedure(s) (hip arthroplasty, knee arthroplasty, kyphoplasty and vertebroplasty), [B] type of end-user(s) (ambulatory surgery centers, hospitals and specialty clinics), and [C] key geographies (North America (the US, Canada and Mexico), Europe (EU5 countries), Asia-Pacific and Rest of the World (Australia, China, India, and Japan)). It is worth mentioning that we adopted a bottom up approach for this analysis, backing our claims with relevant datapoints and credible inputs from primary research. Market estimates have been provided both in terms of value (USD billion) and volume (units of systems).

Chapter 13 summarizes the entire report. It presents a list of key takeaways and offers our independent opinion on the bone cement delivery systems market scenario. Further, it captures the evolutionary trends that are likely to determine the future of this segment of the pharmaceutical industry.

Chapter 14 is a collection of interview transcripts of the discussions that were held with key stakeholders in this market. In this chapter, we have presented the details of interviews held with (in alphabetical order of organization names) Soren Toksvig-Larsen (Associate Professor, Department of Orhopedics, Lund University), John Williams (Director of Musculoskeletal and Renal Biology Programs, Division of Aging Biology, National Institutes of Health), Francesco De Paola (International Product Manager, Medacta International), and Ana Bettencourt (Associate Professor, University of Lisbon).

Chapter 15 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.

Chapter 16 is an appendix, which contains the list of companies and organizations mentioned in the report.

Table of Contents

1. PREFACE

  • 1.1. Chapter Overview
  • 1.2. Research Methodology
  • 1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Concept of Bone Cements
    • 3.2.1. Historical Evolution
    • 3.2.2. Classification
    • 3.2.3. Key Constituents
    • 3.2.4. Methods of Preparation
    • 3.2.5. Factors Affecting Physiochemical Properties
  • 3.3. An Overview of Bone Cement Delivery Systems
    • 3.3.1. Key Features
    • 3.3.2. Types of Devices Based on Mode of Administration
  • 3.4. Key Application Areas
    • 3.4.1. Vertebral Compression Fractures
      • 3.4.1.1. Vertebroplasty
      • 3.4.1.2. Kyphoplasty
    • 3.4.2. Arthroplasty
    • 3.4.3. Other Application Areas
  • 3.5. Advantages and Limitations of Bone Cement Delivery Systems
  • 3.6. Concluding Remarks

4. MARKET LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2. Bone Cement Delivery Systems: List of Devices
    • 4.2.1. Analysis by System Functionality
    • 4.2.2. Analysis by Type of Surgical Procedure
    • 4.2.3. Analysis by Type of Bone Cement
    • 4.2.4. Analysis by Viscosity of Bone Cement
    • 4.2.5. Analysis by Approval Year
    • 4.2.6. Analysis by Volume / Storage Capability
  • 4.3. Bone Cement Delivery Systems: List of Device Developers
    • 4.3.1. Analysis by Year of Establishment
    • 4.3.2. Analysis by Location of Headquarters
    • 4.3.3. Analysis by Size of Company
    • 4.3.4. Leading Developers: Analysis by Number of Devices
    • 4.3.5. Developer Landscape: Analysis by Company Size and Location of Headquarters
  • 4.4. List of Bone Cement Mixing Systems
  • 4.5. Concluding Remarks

5. REGULATORY LANDCSAPE

  • 5.1. Chapter Overview
  • 5.2. Regulatory Guidelines in North America
    • 5.2.1. The US Scenario
    • 5.2.2. Canadian Scenario
  • 5.3. Regulatory Guidelines in Europe
  • 5.4. Regulatory Guidelines in Asia-Pacific and Rest of the World
    • 5.4.1. Japanese Scenario
    • 5.4.2. Chinese Scenario
    • 5.4.3. South African Scenario
  • 5.5. Heat Map Analysis: Comparison of Regional Regulatory Control

6. COMPANY PROFILES

  • 6.1. Chapter Overview
  • 6.2. Profiles of Established Players
    • 6.2.1. DePuy Synthes
      • 6.2.1.1. Company Snapshot
      • 6.2.1.2 Financial Information
      • 6.2.1.3. Device Portfolio
        • 6.2.1.3.1. CONFIDENCE SPINAL CEMENT SYSTEM®
        • 6.2.1.3.2. Device B
        • 6.2.1.3.3. Device C
        • 6.2.1.3.4. Device D
        • 6.2.1.3.5. Device E
        • 6.2.1.3.6. Device F
        • 6.2.1.3.7. Device G
      • 6.2.1.4. Recent Developments and Future Outlook
    • 6.2.2. Medtronic
      • 6.2.2.1 Company Snapshot
      • 6.2.2.2. Financial Information
      • 6.2.2.3. Device Portfolio
        • 6.2.2.3.1. Confidence Bone Cement Delivery System - Fenestrated Introducer Needle
        • 6.3.2.3.2. Device B
        • 6.3.2.3.3. Device C
        • 6.3.2.3.4. Device D
      • 6.3.2.4. Recent Developments and Future Outlook
    • 6.2.3. Merit Medical Systems
      • 6.2.3.1. Company Snapshot
      • 6.2.3.2. Financial Information
      • 6.2.3.3. Device Portfolio
        • 6.2.3.3.1. Osseoflex CD-H Hydraulic Cement Delivery System
        • 6.2.3.3.2. Device B
        • 6.2.3.3.3. Device C
        • 6.2.3.3.4. Device D
        • 6.2.3.3.5. Device E
      • 6.2.3.4. Recent Developments and Future Outlook
    • 6.2.4. Smith & Nephew
      • 6.2.4.1. Company Snapshot
      • 6.2.4.2. Financial Information
      • 6.2.4.3. Device Portfolio
        • 6.2.4.3.1. EZ flow ™ Cement Delivery System
        • 6.2.4.3.2. Device B
        • 6.2.4.3.3. Device C
        • 6.2.4.3.4. Device D
      • 6.2.4.4. Recent Developments and Future Outlook
    • 6.2.5. Stryker
      • 6.2.5.1. Company Snapshot
      • 6.2.5.2. Financial Information
      • 6.2.5.3. Device Portfolio
        • 6.2.5.3.1. ALIQUOT™ Delivery System
        • 6.2.5.3.2. Device B
        • 6.2.5.3.3. Device C
        • 6.2.5.3.4. Device D
        • 6.2.5.3.5. Device E
        • 6.2.5.3.6. Device F
        • 6.2.5.3.7. Device G
        • 6.2.5.3.8. Device H
        • 6.2.5.3.9. Device I
        • 6.2.5.3.10. Device J
      • 6.2.5.4. Recent Developments and Future Outlook
    • 6.2.6. Zimmer Biomet
      • 6.2.6.1. Company Snapshot
      • 6.2.6.2. Financial Information
      • 6.2.6.3. Device Portfolio
        • 6.2.6.3.1. ClearMix™ Vacuum Mixing and Delivery System
        • 6.2.6.3.2. Device B
        • 6.2.6.3.3. Device C
      • 6.2.6.4. Recent Developments and Future Outlook
  • 6.3. Profies of Small-Sized and Mid-Sized Players
    • 6.3.1. Biopsybell
      • 6.3.1.1. Tabular Company Profile
      • 6.3.1.2. Device Portfolio
        • 6.3.1.2.1. Easynject Bone Cement Delivery System
        • 6.3.1.2.2. Device B
        • 6.3.1.2.3. Device C
    • 6.3.2. iMedicom
      • 6.3.2.1. Tabular Company Profile
      • 6.3.2.2. Device Portfolio
        • 6.3.2.2.1. MEDINAUT™-X IBE System
        • 6.3.2.2.2. Device B
        • 6.3.2.2.3. Device C
    • 6.3.3. IZI Medical Products
      • 6.3.3.1. Tabular Company Profile
      • 6.3.3.2. Device Portfolio
        • 6.3.3.2.1. Blazer-C Vertebral Augmentation System
        • 6.3.3.2.2. Device B
        • 6.3.3.2.3. Device C
        • 6.3.3.2.4. Device D
    • 6.3.4. Spirit Spine
      • 6.3.4.1. Tabular Company Profile
      • 6.3.4.2. Device Portfolio
        • 6.3.4.2.1. Controllable Cement Delivery System
        • 6.3.4.2.2. Device B
        • 6.3.4.2.3. Device C
        • 6.3.4.2.4. Device D
    • 6.3.5. Synimed
      • 6.3.5.1. Tabular Company Profile
      • 6.3.5.2. Device Portfolio
        • 6.3.5.2.1. APV Synicem Vertebroplasty System
        • 6.3.5.2.2. Device B
        • 6.3.5.2.3. Device C
        • 6.3.5.2.4. Device D

7. MERGERS AND ACQUISITIONS

  • 7.1. Chapter Overview
  • 7.2. Acquisition Models
  • 7.3. Bone Cement Delivery Systems: Mergers and Acquisitions
    • 7.3.1. Cumulative Year-wise Trend
    • 7.3.2. Analysis by Type of Acquisition
    • 7.3.3. Analysis by Year and Amount of Acquisition
    • 7.3.4. Geographical Activity
    • 7.3.5. Ownership Change Matrix
    • 7.3.6. Most Active Acquirers: Analysis by Number of Acquisitions
    • 7.3.7. Key Value Drivers
    • 7.3.8. Valuation Analysis: Deal Multiples of Key Acquisitions

8. PATENT ANALYSIS

  • 8.1. Chapter Overview
  • 8.2. Scope and Methodology
  • 8.3. Bone Cement Delivery Systems: Patent Analysis
    • 8.3.1. Analysis by Publication Year
    • 8.3.2. Analysis by Geographical Location
    • 8.3.3. Analysis by Type of Surgical Procedure
    • 8.3.4. Analysis by CPC Classifications
    • 8.3.5. Emerging Focus Areas
    • 8.3.6. Analysis by Type of Industry
    • 8.3.7. Leading Players: Analysis by Number of Patents
  • 8.4. Bone Cement Delivery Systems: Patent Benchmarking Analysis
    • 8.4.1. Analysis by Patent Characteristics
      • 8.4.1.1. DePuy Synthes and Medtronic
      • 8.4.1.2. Other Leading Patent Assignees
  • 8.5. Bone Cement Delivery Systems: Patent Valuation Analysis
  • 8.6. Case Study: Analysis of Expired Patents

9. CLINICAL TRIAL ANALYSIS

  • 9.1. Chapter Overview
  • 9.2. Scope and Methodology
  • 9.3. Bone Cements and Associated Delivery Systems: Clinical Trial Analysis
    • 9.3.1. Analysis by Trial Registration Year
    • 9.3.2. Analysis by Trial Phase
    • 9.3.3. Analysis by Study Design
    • 9.3.4. Analysis by Study Intervention
    • 9.3.5. Analysis by Type of Surgical Procedure
    • 9.3.6. Geographical Analysis by Number of Clinical Trials
    • 9.3.7. Geographical Analysis by Enrolled Patient Population
    • 9.3.8. Analysis by Trial Recruitment Status
    • 9.3.9. Analysis by Type of Sponsors / Collaborators
    • 9.3.10. Leading Players: Analysis by Number of Trials
    • 9.3.11. Analysis by Trial Focus
    • 9.3.12. Analysis by Clinical Trial End Points

10. GRANT ANALYSIS

  • 10.1. Chapter Overview
  • 10.2. Scope and Methodology
  • 10.3. Bone Cements: List of Grants
    • 10.3.1. Analysis by Emerging Focus Areas
    • 10.3.2. Analysis by Year of Award
    • 10.3.3. Analysis by Support Period
    • 10.3.4. Analysis by Amount Awarded
    • 10.3.5. Analysis by Amount Awarded and Type of Surgical Procedure
    • 10.3.6. Analysis by Grant Type
    • 10.3.7. Analysis by Grant Type and Type of Surgical Procedure
    • 10.3.8. Analysis by Responsible Study Section
    • 10.3.9. Analysis by Type of Bone Cement

11. DEMAND ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Scope and Methodology
  • 11.3. Global Demand for Bone Cement Delivery Systems, 2019-2030
    • 11.3.1. Global Demand for Bone Cement Delivery Systems: Distribution by Type of Surgical Procedure
      • 11.3.1.1. Global Demand for Bone Cement Delivery Systems for Hip Arthroplasty
      • 11.3.1.2. Global Demand for Bone Cement Delivery Systems for Knee Arthroplasty
      • 11.3.1.3. Global Demand for Bone Cement Delivery Systems for Kyphoplasty
      • 11.3.1.4. Global Demand for Bone Cement Delivery Systems for Vertebroplasty
    • 11.3.2. Global Demand for Bone Cement Delivery Systems: Distribution by Geography
  • 11.4. Demand for Bone Cement Delivery Systems in North America
    • 11.4.1. Demand for Bone Cement Delivery Systems in the US
      • 11.4.1.1. Demand for Bone Cement Delivery Systems in the US for Hip Arthroplasty
      • 11.4.1.2. Demand for Bone Cement Delivery Systems in the US for Knee Arthroplasty
      • 11.4.1.3. Demand for Bone Cement Delivery Systems in the US for Kyphoplasty
      • 11.4.1.4. Demand for Bone Cement Delivery Systems in the US for Vertebroplasty
    • 11.4.2. Demand for Bone Cement Delivery Systems in Canada
      • 11.4.2.1. Demand for Bone Cement Delivery Systems in Canada for Hip Arthroplasty
      • 11.4.2.2. Demand for Bone Cement Delivery Systems in Canada for Knee Arthroplasty
      • 11.4.2.3. Demand for Bone Cement Delivery Systems in Canada for Kyphoplasty
      • 11.4.2.4. Demand for Bone Cement Delivery Systems in Canada for Vertebroplasty
    • 11.4.3. Demand for Bone Cement Delivery Systems in Mexico
      • 11.4.3.1. Demand for Bone Cement Delivery Systems in Mexico for Hip Arthroplasty
      • 11.4.3.2. Demand for Bone Cement Delivery Systems in Mexico for Knee Arthroplasty
      • 11.4.3.3. Demand for Bone Cement Delivery Systems in Mexico for Kyphoplasty
      • 11.4.3.4. Demand for Bone Cement Delivery Systems in Mexico for Vertebroplasty
  • 11.5. Demand for Bone Cement Delivery Systems in Europe
    • 11.5.1. Demand for Bone Cement Delivery Systems in France
      • 11.5.1.1. Demand for Bone Cement Delivery Systems in France for Hip Arthroplasty
      • 11.5.1.2. Demand for Bone Cement Delivery Systems in France for Knee Arthroplasty
      • 11.5.1.3. Demand for Bone Cement Delivery Systems in France for Kyphoplasty
      • 11.5.1.4. Demand for Bone Cement Delivery Systems in France for Vertebroplasty
    • 11.5.2. Demand for Bone Cement Delivery Systems in Germany
      • 11.5.2.1. Demand for Bone Cement Delivery Systems in Germany for Hip Arthroplasty
      • 11.5.2.2. Demand for Bone Cement Delivery Systems in Germany for Knee Arthroplasty
      • 11.5.2.3. Demand for Bone Cement Delivery Systems in Germany for Kyphoplasty
      • 11.5.2.4. Demand for Bone Cement Delivery Systems in Germany for Vertebroplasty
    • 11.5.3. Demand for Bone Cement Delivery Systems in Italy
      • 11.5.3.1. Demand for Bone Cement Delivery Systems in Italy for Hip Arthroplasty
      • 11.5.3.2. Demand for Bone Cement Delivery Systems in Italy for Knee Arthroplasty
      • 11.5.3.3. Demand for Bone Cement Delivery Systems in Italy for Kyphoplasty
      • 11.5.3.4. Demand for Bone Cement Delivery Systems in Italy for Vertebroplasty
    • 11.5.4. Demand for Bone Cement Delivery Systems in Spain
      • 11.5.4.1. Demand for Bone Cement Delivery Systems in Spain for Hip Arthroplasty
      • 11.5.4.2. Demand for Bone Cement Delivery Systems in Spain for Knee Arthroplasty
      • 11.5.4.3. Demand for Bone Cement Delivery Systems in Spain for Kyphoplasty
      • 11.5.4.4. Demand for Bone Cement Delivery Systems in Spain for Vertebroplasty
    • 11.5.5. Demand for Bone Cement Delivery Systems in the UK
      • 11.5.5.1. Demand for Bone Cement Delivery Systems in the UK for Hip Arthroplasty
      • 11.5.5.2. Demand for Bone Cement Delivery Systems in the UK for Knee Arthroplasty
      • 11.5.5.3. Demand for Bone Cement Delivery Systems in the UK for Kyphoplasty
      • 11.5.5.4. Demand for Bone Cement Delivery Systems in the UK for Vertebroplasty
  • 11.6. Demand for Bone Cement Delivery Systems in Asia-Pacific and Rest of the World
    • 11.6.1. Demand for Bone Cement Delivery Systems in Australia
      • 11.6.1.1. Demand for Bone Cement Delivery Systems in Australia for Hip Arthroplasty
      • 11.6.1.2. Demand for Bone Cement Delivery Systems in Australia for Knee Arthroplasty
      • 11.6.1.3. Demand for Bone Cement Delivery Systems in Australia for Kyphoplasty
      • 11.6.1.4. Demand for Bone Cement Delivery Systems in Australia for Vertebroplasty
    • 11.6.2. Demand for Bone Cement Delivery Systems in China
      • 11.6.2.1. Demand for Bone Cement Delivery Systems in China for Hip Arthroplasty
      • 11.6.2.2. Demand for Bone Cement Delivery Systems in China for Knee Arthroplasty
      • 11.6.2.3. Demand for Bone Cement Delivery Systems in China for Kyphoplasty
      • 11.6.2.4. Demand for Bone Cement Delivery Systems in China for Vertebroplasty
    • 11.6.3. Demand for Bone Cement Delivery Systems in India
      • 11.6.3.1. Demand for Bone Cement Delivery Systems in India for Hip Arthroplasty
      • 11.6.3.2. Demand for Bone Cement Delivery Systems in India for Knee Arthroplasty
      • 11.6.3.3. Demand for Bone Cement Delivery Systems in India for Kyphoplasty
      • 11.6.3.4. Demand for Bone Cement Delivery Systems in India for Vertebroplasty
    • 11.6.4. Demand for Bone Cement Delivery Systems in Japan
      • 11.6.4.1. Demand for Bone Cement Delivery Systems in Japan for Hip Arthroplasty
      • 11.6.4.2. Demand for Bone Cement Delivery Systems in Japan for Knee Arthroplasty
      • 11.6.4.3. Demand for Bone Cement Delivery Systems in Japan for Kyphoplasty
      • 11.6.4.4. Demand for Bone Cement Delivery Systems in Japan for Vertebroplasty
  • 11.7. Concluding Remarks

12. MARKET FORECAST

  • 12.1. Chapter Overview
  • 12.2. Forecast Methodology and Key Assumptions
  • 12.3. Global Bone Cement Delivery Systems Market, 2019-2030
    • 12.3.1. Global Bone Cement Delivery Systems Market, 2019-2030 (By Value)
    • 12.3.2. Global Bone Cement Delivery Systems Market, 2019-2030 (By Volume)
  • 12.4. Global Bone Cement Delivery Systems Market: Distribution by Type of Surgical Procedure
    • 12.4.1. Global Bone Cement Delivery Systems Market: Distribution by Type of Surgical Procedure (By Value)
      • 12.4.1.1. Bone Cement Delivery Systems Market for Hip Arthroplasty, 2019-2030 (By Value)
      • 12.4.1.2. Bone Cement Delivery Systems Market for Knee Arthroplasty, 2019-2030 (By Value)
      • 12.4.1.3. Bone Cement Delivery Systems Market for Kyphoplasty, 2019-2030 (By Value)
      • 12.4.1.4. Bone Cement Delivery Systems Market for Vertebroplasty, 2019-2030 (By Value)
    • 12.4.2. Global Bone Cement Delivery Systems Market: Distribution by Type of Surgical Procedure (By Volume)
      • 12.4.2.1. Bone Cement Delivery Systems Market for Hip Arthroplasty, 2019-2030 (By Volume)
      • 12.4.2.2. Bone Cement Delivery Systems Market for Knee Arthroplasty, 2019-2030 (By Volume)
      • 12.4.2.3. Bone Cement Delivery Systems Market for Kyphoplasty, 2019-2030 (By Volume)
      • 12.4.2.4. Bone Cement Delivery Systems Market for Vertebroplasty, 2019-2030 (By Volume)
  • 12.5. Global Bone Cement Delivery Systems Market: Distribution by Type of End-Users (By Value)
    • 12.5.1. Bone Cement Delivery Systems Market for Ambulatory Surgery Centers, 2019-2030 (By Value)
    • 12.5.2. Bone Cement Delivery Systems Market for Hospitals, 2019-2030 (By Value)
    • 12.5.3. Bone Cement Delivery Systems Market for Specialty Clinics, 2019-2030 (By Value)
  • 12.6. Global Bone Cement Delivery Systems Market: Distribution by Geography
    • 12.6.1. Global Bone Cement Delivery Systems Market: Distribution by Geography (By Value)
      • 12.6.1.1. Bone Cement Delivery Systems Market in North America, 2019-2030 (By Value)
        • 12.6.1.1.1. Bone Cement Delivery Systems Market in the US, 2019-2030 (By Value)
        • 12.6.1.1.2. Bone Cement Delivery Systems Market in Canada, 2019-2030 (By Value)
        • 12.6.1.1.3. Bone Cement Delivery Systems Market in Mexico, 2019-2030 (By Value)
      • 12.6.1.2. Bone Cement Delivery Systems Market in Europe, 2019-2030 (By Value)
        • 12.6.1.2.1. Bone Cement Delivery Systems Market in France, 2019-2030 (By Value)
        • 12.6.1.2.2. Bone Cement Delivery Systems Market in Germany, 2019-2030 (By Value)
        • 12.6.1.2.3. Bone Cement Delivery Systems Market in Italy, 2019-2030 (By Value)
        • 12.6.1.2.4. Bone Cement Delivery Systems Market in Spain, 2019-2030 (By Value)
        • 12.6.1.2.5. Bone Cement Delivery Systems Market in the UK, 2019-2030 (By Value)
      • 12.6.1.3. Bone Cement Delivery Systems Market in Asia-Pacific and Rest of the World, 2019-2030 (By Value)
        • 12.6.1.3.1. Bone Cement Delivery Systems Market in Australia, 2019-2030 (By Value)
        • 12.6.1.3.2. Bone Cement Delivery Systems Market in China, 2019-2030 (By Value)
        • 12.6.1.3.3. Bone Cement Delivery Systems Market in India, 2019-2030 (By Value)
        • 12.6.1.3.4. Bone Cement Delivery Systems Market in Japan, 2019-2030 (By Value)
    • 12.6.2. Global Bone Cement Delivery Systems Market: Distribution by Geography (By Volume)
      • 12.6.2.1. Bone Cement Delivery Systems Market in North America, 2019-2030 (By Volume)
        • 12.6.2.1.1. Bone Cement Delivery Systems Market in the US, 2019-2030 (By Volume)
        • 12.6.2.1.2. Bone Cement Delivery Systems Market in Canada, 2019-2030 (By Volume)
        • 12.6.2.1.3. Bone Cement Delivery Systems Market in Mexico, 2019-2030 (By Volume)
      • 12.6.2.2. Bone Cement Delivery Systems Market in Europe, 2019-2030 (By Volume)
        • 12.6.2.2.1. Bone Cement Delivery Systems Market in France, 2019-2030 (By Volume)
        • 12.6.2.2.2. Bone Cement Delivery Systems Market in Germany, 2019-2030 (By Volume)
        • 12.6.2.2.3. Bone Cement Delivery Systems Market in Italy, 2019-2030 (By Volume)
        • 12.6.2.2.4. Bone Cement Delivery Systems Market in Spain, 2019-2030 (By Volume)
        • 12.6.2.2.5. Bone Cement Delivery Systems Market in the UK, 2019-2030 (By Volume)
      • 12.6.2.3. Bone Cement Delivery Systems Market in Asia-Pacific and Rest of the World, 2019-2030 (By Volume)
        • 12.6.2.3.1. Bone Cement Delivery Systems Market in Australia, 2019-2030 (By Volume)
        • 12.6.2.3.2. Bone Cement Delivery Systems Market in China, 2019-2030 (By Volume)
        • 12.6.2.3.3. Bone Cement Delivery Systems Market in India, 2019-2030 (By Volume)
        • 12.6.2.3.4. Bone Cement Delivery Systems Market in Japan, 2019-2030 (By Volume)
  • 12.7. Global Bone Cement Delivery Systems Market: Distribution by Type of Surgical Procedure and Geography
    • 12.7.1. Global Bone Cement Delivery Systems Market: Distribution by Type of Surgical Procedure and Geography (By Value)
      • 12.7.1.1. Bone Cement Delivery Systems Market for Hip Arthroplasty in North America, 2019-2030 (By Value)
        • 12.7.1.1.1. Bone Cement Delivery Systems Market for Hip Arthroplasty in the US, 2019-2030 (By Value)
        • 12.7.1.1.2. Bone Cement Delivery Systems Market for Hip Arthroplasty in Canada, 2019-2030 (By Value)
        • 12.7.1.1.3. Bone Cement Delivery Systems Market for Hip Arthroplasty in Mexico, 2019-2030 (By Value)
      • 12.7.1.2. Bone Cement Delivery Systems Market for Hip Arthroplasty in Europe, 2019-2030 (By Value)
        • 12.7.1.2.1. Bone Cement Delivery Systems Market for Hip Arthroplasty in France, 2019-2030 (By Value)
        • 12.7.1.2.2. Bone Cement Delivery Systems Market for Hip Arthroplasty in Germany, 2019-2030 (By Value)
        • 12.7.1.2.3. Bone Cement Delivery Systems Market for Hip Arthroplasty in Italy, 2019-2030 (By Value)
        • 12.7.1.2.4. Bone Cement Delivery Systems Market for Hip Arthroplasty in Spain, 2019-2030 (By Value)
        • 12.7.1.2.5. Bone Cement Delivery Systems Market for Hip Arthroplasty in the UK, 2019-2030 (By Value)
      • 12.7.1.3. Bone Cement Delivery Systems Market for Hip Arthroplasty in Asia-Pacific and Rest of the World, 2019-2030 (By Value)
        • 12.7.1.3.1. Bone Cement Delivery Systems Market for Hip Arthroplasty in Australia, 2019-2030 (By Value)
        • 12.7.1.3.2. Bone Cement Delivery Systems Market for Hip Arthroplasty in China, 2019-2030 (By Value)
        • 12.7.1.3.3. Bone Cement Delivery Systems Market for Hip Arthroplasty in India, 2019-2030 (By Value)
        • 12.7.1.3.4. Bone Cement Delivery Systems Market for Hip Arthroplasty in Japan, 2019-2030 (By Value)
      • 12.7.1.4. Bone Cement Delivery Systems Market for Knee Arthroplasty in North America, 2019-2030 (By Value)
        • 12.7.1.4.1. Bone Cement Delivery Systems Market for Knee Arthroplasty in the US, 2019-2030 (By Value)
        • 12.7.1.4.2. Bone Cement Delivery Systems Market for Knee Arthroplasty in Canada, 2019-2030 (By Value)
        • 12.7.1.4.3. Bone Cement Delivery Systems Market for Knee Arthroplasty in Mexico, 2019-2030 (By Value)
      • 12.7.1.5. Bone Cement Delivery Systems Market for Knee Arthroplasty in Europe, 2019-2030 (By Value)
        • 12.7.1.5.1. Bone Cement Delivery Systems Market for Knee Arthroplasty in France, 2019-2030 (By Value)
        • 12.7.1.5.2. Bone Cement Delivery Systems Market for Knee Arthroplasty in Germany, 2019-2030 (By Value)
        • 12.7.1.5.3. Bone Cement Delivery Systems Market for Knee Arthroplasty in Italy, 2019-2030 (By Value)
        • 12.7.1.5.4. Bone Cement Delivery Systems Market for Knee Arthroplasty in Spain, 2019-2030 (By Value)
        • 12.7.1.5.5. Bone Cement Delivery Systems Market for Knee Arthroplasty in the UK, 2019-2030 (By Value)
      • 12.7.1.6. Bone Cement Delivery Systems Market for Knee Arthroplasty in Asia-Pacific and Rest of the World, 2019-2030 (By Value)
        • 12.7.1.6.1. Bone Cement Delivery Systems Market for Knee Arthroplasty in Australia, 2019-2030 (By Value)
        • 12.7.1.6.2. Bone Cement Delivery Systems Market for Knee Arthroplasty in China, 2019-2030 (By Value)
        • 12.7.1.6.3. Bone Cement Delivery Systems Market for Knee Arthroplasty in India, 2019-2030 (By Value)
        • 12.7.1.6.4. Bone Cement Delivery Systems Market for Knee Arthroplasty in Japan, 2019-2030 (By Value)
      • 12.7.1.7. Bone Cement Delivery Systems Market for Kyphoplasty in North America, 2019-2030 (By Value)
        • 12.7.1.7.1. Bone Cement Delivery Systems Market for Kyphoplasty in the US, 2019-2030 (By Value)
        • 12.7.1.7.2. Bone Cement Delivery Systems Market for Kyphoplasty in Canada, 2019-2030 (By Value)
        • 12.7.1.7.3. Bone Cement Delivery Systems Market for Kyphoplasty in Mexico, 2019-2030 (By Value)
      • 12.7.1.8. Bone Cement Delivery Systems Market for Kyphoplasty in Europe, 2019-2030 (By Value)
        • 12.7.1.8.1. Bone Cement Delivery Systems Market for Kyphoplasty in France, 2019-2030 (By Value)
        • 12.7.1.8.2. Bone Cement Delivery Systems Market for Kyphoplasty in Germany, 2019-2030 (By Value)
        • 12.7.1.8.3. Bone Cement Delivery Systems Market for Kyphoplasty in Italy, 2019-2030 (By Value)
        • 12.7.1.8.4. Bone Cement Delivery Systems Market for Kyphoplasty in Spain, 2019-2030 (By Value)
        • 12.7.1.8.5. Bone Cement Delivery Systems Market for Kyphoplasty in the UK, 2019-2030 (By Value)
      • 12.7.1.9. Bone Cement Delivery Systems Market for Kyphoplasty in Asia-Pacific and Rest of the World, 2019-2030 (By Value)
        • 12.7.1.9.1. Bone Cement Delivery Systems Market for Kyphoplasty in Australia, 2019-2030 (By Value)
        • 12.7.1.9.2. Bone Cement Delivery Systems Market for Kyphoplasty in China, 2019-2030 (By Value)
        • 12.7.1.9.3. Bone Cement Delivery Systems Market for Kyphoplasty in India, 2019-2030 (By Value)
        • 12.7.1.9.4. Bone Cement Delivery Systems Market for Kyphoplasty in Japan, 2019-2030 (By Value)
      • 12.7.1.10. Bone Cement Delivery Systems Market for Vertebroplasty in North America, 2019-2030 (By Value)
        • 12.7.1.10.1. Bone Cement Delivery Systems Market for Vertebroplasty in the US, 2019-2030 (By Value)
        • 12.7.1.10.2. Bone Cement Delivery Systems Market for Vertebroplasty in Canada, 2019-2030 (By Value)
        • 12.7.1.10.3. Bone Cement Delivery Systems Market for Vertebroplasty in Mexico, 2019-2030 (By Value)
      • 12.7.1.11. Bone Cement Delivery Systems Market for Vertebroplasty in Europe, 2019-2030 (By Value)
        • 12.7.1.11.1. Bone Cement Delivery Systems Market for Vertebroplasty in France, 2019-2030 (By Value)
        • 12.7.1.11.2. Bone Cement Delivery Systems Market for Vertebroplasty in Germany, 2019-2030 (By Value)
        • 12.7.1.11.3. Bone Cement Delivery Systems Market for Vertebroplasty in Italy, 2019-2030 (By Value)
        • 12.7.1.11.4. Bone Cement Delivery Systems Market for Vertebroplasty in Spain, 2019-2030 (By Value)
        • 12.7.1.11.5. Bone Cement Delivery Systems Market for Vertebroplasty in the UK, 2019-2030 (By Value)
      • 12.7.1.12. Bone Cement Delivery Systems Market for Vertebroplasty in Asia-Pacific and Rest of the World, 2019-2030 (By Value)
        • 12.7.1.12.1. Bone Cement Delivery Systems Market for Vertebroplasty in Australia, 2019-2030 (By Value)
        • 12.7.1.12.2. Bone Cement Delivery Systems Market for Vertebroplasty in China, 2019-2030 (By Value)
        • 12.7.1.12.3. Bone Cement Delivery Systems Market for Vertebroplasty in India, 2019-2030 (By Value)
        • 12.7.1.12.4. Bone Cement Delivery Systems Market for Vertebroplasty in Japan, 2019-2030 (By Value)
    • 12.7.2. Global Bone Cement Delivery Systems Market: Distribution by Type of Surgical Procedure and Geography (By Volume)
      • 12.7.2.1. Bone Cement Delivery Systems Market for Hip Arthroplasty in North America, 2019-2030 (By Volume)
        • 12.7.2.1.1. Bone Cement Delivery Systems Market for Hip Arthroplasty in the US, 2019-2030 (By Volume)
        • 12.7.2.1.2. Bone Cement Delivery Systems Market for Hip Arthroplasty in Canada, 2019-2030 (By Volume)
        • 12.7.2.1.3. Bone Cement Delivery Systems Market for Hip Arthroplasty in Mexico, 2019-2030 (By Volume)
      • 12.7.2.2. Bone Cement Delivery Systems Market for Hip Arthroplasty in Europe, 2019-2030 (By Volume)
        • 12.7.2.2.1. Bone Cement Delivery Systems Market for Hip Arthroplasty in France, 2019-2030 (By Volume)
        • 12.7.2.2.2. Bone Cement Delivery Systems Market for Hip Arthroplasty in Germany, 2019-2030 (By Volume)
        • 12.7.2.2.3. Bone Cement Delivery Systems Market for Hip Arthroplasty in Italy, 2019-2030 (By Volume)
        • 12.7.2.2.4. Bone Cement Delivery Systems Market for Hip Arthroplasty in Spain, 2019-2030 (By Volume)
        • 12.7.2.2.5. Bone Cement Delivery Systems Market for Hip Arthroplasty in the UK, 2019-2030 (By Volume)
      • 12.7.2.3. Bone Cement Delivery Systems Market for Hip Arthroplasty in Asia-Pacific and Rest of the World, 2019-2030 (By Volume)
        • 12.7.2.3.1. Bone Cement Delivery Systems Market for Hip Arthroplasty in Australia, 2019-2030 (By Volume)
        • 12.7.2.3.2. Bone Cement Delivery Systems Market for Hip Arthroplasty in China, 2019-2030 (By Volume)
        • 12.7.2.3.3. Bone Cement Delivery Systems Market for Hip Arthroplasty in India, 2019-2030 (By Volume)
        • 12.7.2.3.4. Bone Cement Delivery Systems Market for Hip Arthroplasty in Japan, 2019-2030 (By Volume)
      • 12.7.2.4. Bone Cement Delivery Systems Market for Knee Arthroplasty in North America, 2019-2030 (By Volume)
        • 12.7.2.4.1. Bone Cement Delivery Systems Market for Knee Arthroplasty in the US, 2019-2030 (By Volume)
        • 12.7.2.4.2. Bone Cement Delivery Systems Market for Knee Arthroplasty in Canada, 2019-2030 (By Volume)
        • 12.7.2.4.3. Bone Cement Delivery Systems Market for Knee Arthroplasty in Mexico, 2019-2030 (By Volume)
      • 12.7.2.5. Bone Cement Delivery Systems Market for Knee Arthroplasty in Europe, 2019-2030 (By Volume)
        • 12.7.2.5.1. Bone Cement Delivery Systems Market for Knee Arthroplasty in France, 2019-2030 (By Volume)
        • 12.7.2.5.2. Bone Cement Delivery Systems Market for Knee Arthroplasty in Germany, 2019-2030 (By Volume)
        • 12.7.2.5.3. Bone Cement Delivery Systems Market for Knee Arthroplasty in Italy, 2019-2030 (By Volume)
        • 12.7.2.5.4. Bone Cement Delivery Systems Market for Knee Arthroplasty in Spain, 2019-2030 (By Volume)
        • 12.7.2.5.5. Bone Cement Delivery Systems Market for Knee Arthroplasty in the UK, 2019-2030 (By Volume)
      • 12.7.2.6. Bone Cement Delivery Systems Market for Knee Arthroplasty in Asia-Pacific and Rest of the World, 2019-2030 (By Volume)
        • 12.7.2.6.1. Bone Cement Delivery Systems Market for Knee Arthroplasty in Australia, 2019-2030 (By Volume)
        • 12.7.2.6.2. Bone Cement Delivery Systems Market for Knee Arthroplasty in China, 2019-2030 (By Volume)
        • 12.7.2.6.3. Bone Cement Delivery Systems Market for Knee Arthroplasty in India, 2019-2030 (By Volume)
        • 12.7.2.6.4. Bone Cement Delivery Systems Market for Knee Arthroplasty in Japan, 2019-2030 (By Volume)
      • 12.7.2.7. Bone Cement Delivery Systems Market for Kyphoplasty in North America, 2019-2030 (By Volume)
        • 12.7.2.7.1. Bone Cement Delivery Systems Market for Kyphoplasty in the US, 2019-2030 (By Volume)
        • 12.7.2.7.2. Bone Cement Delivery Systems Market for Kyphoplasty in Canada, 2019-2030 (By Volume)
        • 12.7.2.7.3. Bone Cement Delivery Systems Market for Kyphoplasty in Mexico, 2019-2030 (By Volume)
      • 12.7.2.8. Bone Cement Delivery Systems Market for Kyphoplasty in Europe, 2019-2030 (By Volume)
        • 12.7.2.8.1. Bone Cement Delivery Systems Market for Kyphoplasty in France, 2019-2030 (By Volume)
        • 12.7.2.8.2. Bone Cement Delivery Systems Market for Kyphoplasty in Germany, 2019-2030 (By Volume)
        • 12.7.2.8.3. Bone Cement Delivery Systems Market for Kyphoplasty in Italy, 2019-2030 (By Volume)
        • 12.7.2.8.4. Bone Cement Delivery Systems Market for Kyphoplasty in Spain, 2019-2030 (By Volume)
        • 12.7.2.8.5. Bone Cement Delivery Systems Market for Kyphoplasty in the UK, 2019-2030 (By Volume)
      • 12.7.2.9. Bone Cement Delivery Systems Market for Kyphoplasty in Asia-Pacific and Rest of the World, 2019-2030 (By Volume)
        • 12.7.2.9.1. Bone Cement Delivery Systems Market for Kyphoplasty in Australia, 2019-2030 (By Volume)
        • 12.7.2.9.2. Bone Cement Delivery Systems Market for Kyphoplasty in China, 2019-2030 (By Volume)
        • 12.7.2.9.3. Bone Cement Delivery Systems Market for Kyphoplasty in India, 2019-2030 (By Volume)
        • 12.7.2.9.4. Bone Cement Delivery Systems Market for Kyphoplasty in Japan, 2019-2030 (By Volume)
      • 12.7.2.10. Bone Cement Delivery Systems Market for Vertebroplasty in North America, 2019-2030 (By Volume)
        • 12.7.2.10.1. Bone Cement Delivery Systems Market for Vertebroplasty in the US, 2019-2030 (By Volume)
        • 12.7.2.10.2. Bone Cement Delivery Systems Market for Vertebroplasty in Canada, 2019-2030 (By Volume)
        • 12.7.2.10.3. Bone Cement Delivery Systems Market for Vertebroplasty in Mexico, 2019-2030 (By Volume)
      • 12.7.2.11. Bone Cement Delivery Systems Market for Vertebroplasty in Europe, 2019-2030 (By Volume)
        • 12.7.2.11.1. Bone Cement Delivery Systems Market for Vertebroplasty in France, 2019-2030 (By Volume)
        • 12.7.2.11.2. Bone Cement Delivery Systems Market for Vertebroplasty in Germany, 2019-2030 (By Volume)
        • 12.7.2.11.3. Bone Cement Delivery Systems Market for Vertebroplasty in Italy, 2019-2030 (By Volume)
        • 12.7.2.11.4. Bone Cement Delivery Systems Market for Vertebroplasty in Spain, 2019-2030 (By Volume)
        • 12.7.2.11.5. Bone Cement Delivery Systems Market for Vertebroplasty in the UK, 2019-2030 (By Volume)
      • 12.7.1.12. Bone Cement Delivery Systems Market for Vertebroplasty in Asia-Pacific and Rest of the World, 2019-2030 (By Volume)
        • 12.7.2.12.1. Bone Cement Delivery Systems Market for Vertebroplasty in Australia, 2019-2030 (By Volume)
        • 12.7.2.12.2. Bone Cement Delivery Systems Market for Vertebroplasty in China, 2019-2030 (By Volume)
        • 12.7.2.12.3. Bone Cement Delivery Systems Market for Vertebroplasty in India, 2019-2030 (By Volume)
        • 12.7.2.12.4. Bone Cement Delivery Systems Market for Vertebroplasty in Japan, 2019-2030 (By Volume)
  • 12.8. Global Bone Cement Delivery Systems Market: Distribution by Type of End-User and Geography (By Value)
    • 12.8.1. Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in North America, 2019-2030 (By Value)
      • 12.8.1.1. Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in the US, 2019-2030 (By Value)
      • 12.8.1.2. Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Canada, 2019-2030 (By Value)
      • 12.8.1.3. Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Mexico, 2019-2030 (By Value)
    • 12.8.2. Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Europe, 2019-2030 (By Value)
      • 12.8.2.1. Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in France, 2019-2030 (By Value)
      • 12.8.2.2. Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Germany, 2019-2030 (By Value)
      • 12.8.2.3. Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Italy, 2019-2030 (By Value)
      • 12.8.2.4. Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Spain, 2019-2030 (By Value)
      • 12.8.2.5. Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in the UK, 2019-2030 (By Value)
    • 12.8.3. Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Asia-Pacific and Rest of the World, 2019-2030 (By Value)
      • 12.8.3.1. Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Australia, 2019-2030 (By Value)
      • 12.8.3.2. Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in China, 2019-2030 (By Value)
      • 12.8.3.3. Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in India, 2019-2030 (By Value)
      • 12.8.3.4. Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Japan, 2019-2030 (By Value)
    • 12.8.4. Bone Cement Delivery Systems Market for Hospitals in North America, 2019-2030 (By Value)
      • 12.8.4.1. Bone Cement Delivery Systems Market for Hospitals in the US, 2019-2030 (By Value)
      • 12.8.4.2. Bone Cement Delivery Systems Market for Hospitals in Canada, 2019-2030 (By Value)
      • 12.8.4.3. Bone Cement Delivery Systems Market for Hospitals in Mexico, 2019-2030 (By Value)
    • 12.8.5. Bone Cement Delivery Systems Market for Hospitals in Europe, 2019-2030 (By Value)
      • 12.8.5.1. Bone Cement Delivery Systems Market for Hospitals in France, 2019-2030 (By Value)
      • 12.8.5.2. Bone Cement Delivery Systems Market for Hospitals in Germany, 2019-2030 (By Value)
      • 12.8.5.3. Bone Cement Delivery Systems Market for Hospitals in Italy, 2019-2030 (By Value)
      • 12.8.5.4. Bone Cement Delivery Systems Market for Hospitals in Spain, 2019-2030 (By Value)
      • 12.8.5.5. Bone Cement Delivery Systems Market for Hospitals in the UK, 2019-2030 (By Value)
    • 12.8.6. Bone Cement Delivery Systems Market for Hospitals in Asia-Pacific and Rest of the World, 2019-2030 (By Value)
      • 12.8.6.1. Bone Cement Delivery Systems Market for Hospitals in Australia, 2019-2030 (By Value)
      • 12.8.6.2. Bone Cement Delivery Systems Market for Hospitals in China, 2019-2030 (By Value)
      • 12.8.6.3. Bone Cement Delivery Systems Market for Hospitals in India, 2019-2030 (By Value)
      • 12.8.6.4. Bone Cement Delivery Systems Market for Hospitals in Japan, 2019-2030 (By Value)
    • 12.8.7. Bone Cement Delivery Systems Market for Specialty Clinics in North America, 2019-2030 (By Value)
      • 12.8.7.1. Bone Cement Delivery Systems Market for Specialty Clinics in the US, 2019-2030 (By Value)
      • 12.8.7.2. Bone Cement Delivery Systems Market for Specialty Clinics in Canada, 2019-2030 (By Value)
      • 12.8.7.3. Bone Cement Delivery Systems Market for Specialty Clinics in Mexico, 2019-2030 (By Value)
    • 12.8.8. Bone Cement Delivery Systems Market for Specialty Clinics in Europe, 2019-2030 (By Value)
      • 12.8.8.1. Bone Cement Delivery Systems Market for Specialty Clinics in France, 2019-2030 (By Value)
      • 12.8.8.2. Bone Cement Delivery Systems Market for Specialty Clinics in Germany, 2019-2030 (By Value)
      • 12.8.8.3. Bone Cement Delivery Systems Market for Specialty Clinics in Italy, 2019-2030 (By Value)
      • 12.8.8.4. Bone Cement Delivery Systems Market for Specialty Clinics in Spain, 2019-2030 (By Value)
      • 12.8.8.5. Bone Cement Delivery Systems Market for Specialty Clinics in the UK, 2019-2030 (By Value)
    • 12.8.9. Bone Cement Delivery Systems Market for Specialty Clinics in Asia-Pacific and Rest of the World, 2019-2030 (By Value)
      • 12.8.9.1. Bone Cement Delivery Systems Market for Specialty Clinics in Australia, 2019-2030 (By Value)
      • 12.8.9.2. Bone Cement Delivery Systems Market for Specialty Clinics in China, 2019-2030 (By Value)
      • 12.8.9.3. Bone Cement Delivery Systems Market for Specialty Clinics in India, 2019-2030 (By Value)
      • 12.8.9.4. Bone Cement Delivery Systems Market for Specialty Clinics in Japan, 2019-2030 (By Value)

13. CONCLUSION

  • 13.1. Rise in Incidence of Osteoporotic Fractures and Accidental Bone Injuries among Elderly Individuals has Elevated the Demand for Cemented Orthopedic Surgeries
  • 13.2. Presently, a Variety of Proprietary Bone Cement Delivery Systems, Having Different Specifications, are Available for Use across Various Orthopedic Procedures
  • 13.3. The Fragmented Developer Landscape includes Small, Mid-Sized and Established Players, Majority of which are based in North America and Europe
  • 13.4. In the Recent Past, Several Strategic Acquisitions have been Reported in this Domain; Key Value Drivers include Portfolio and Geographical Consolidation
  • 13.5. Innovation in this Domain is Evident in the Plethora of Patents Filed Related to Bone Cement Delivery Systems across Different Regions
  • 13.6. The Field has Witnessed a Number of Grant Awards in the Recent Past; A Proportion of these Grants were Aimed to Support Clinical Research Initiatives
  • 13.7. Driven by an Increasing Demand for Cemented Surgeries, the Market is Anticipated to Grow at a Steady Pace over the Coming Decade

14. EXECUTIVE INSIGHTS

  • 14.1. Chapter Overview
  • 14.2. Soren Toksvig-Larsen, Associate Professor, Department of Orthopedics, Lund University
  • 14.3. John Williams, Director of Musculoskeletal and Renal Biology Programs, Division of Aging Biology, National Institutes of Health
  • 14.4. Francesco De Paola, International Product Manager, Medacta International
  • 14.5. Ana Bettencourt, Associate Professor, University of Lisbon

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Figures

  • Figure 3.1: Historical Evolution of Bone Cements
  • Figure 3.2: Classification of Bone Cements
  • Figure 3.3: Key Constituents of Bone Cements
  • Figure 3.4: Materials Used to Enhance Preparation of Bone Cements
  • Figure 3.5: Approaches to Augment the Structural Integrity of Radio-pacified Bone Cements
  • Figure 3.6: Bone Cement Preparation Process
  • Figure 3.7: Phases of Polymerization in Bone Cement Preparation
  • Figure 3.8: Techniques Used for Mixing Bone Cements
  • Figure 3.9: Key Features of Bone Cement Delivery Systems
  • Figure 3.10: Types of Bone Cement Delivery Systems
  • Figure 3.11: Key Steps Involved in Vertebroplasty
  • Figure 3.12: Key Steps Involved in Kyphoplasty
  • Figure 3.13: Types of Arthroplasty
  • Figure 3.14: Key Steps Involved in Arthroplasty
  • Figure 3.15: Advantages and Limitations Related to Bone Cement Delivery Systems
  • Figure 4.1: Bone Cement Delivery Systems: Distribution by System Functionality
  • Figure 4.2: Bone Cement Delivery Systems: Distribution by Type of Surgical Procedure
  • Figure 4.3: Bone Cement Delivery Systems: Distribution by Type of Bone Cement
  • Figure 4.4: Bone Cement Delivery Systems: Distribution by Viscosity of Bone Cement
  • Figure 4.5: Bone Cement Delivery Systems: Distribution by Type and Viscosity of Bone Cement
  • Figure 4.6: Bone Cement Delivery Systems: Distribution by Type of Surgical Procedure and Viscosity of Bone Cement
  • Figure 4.7: Bone Cement Delivery Systems: Distribution by Approval Year
  • Figure 4.8: Bone Cement Delivery Systems: Distribution of Developers by Year of Establishment
  • Figure 4.9: Bone Cement Delivery Systems: Distribution of Developers by Location of Headquarters
  • Figure 4.10: Bone Cement Delivery Systems: Distribution Developers by Size of Company
  • Figure 4.11: Leading Developers: Distribution by Number of Devices
  • Figure 4.12: Developer Landscape: Distribution by Company Size and Location of Headquarters
  • Figure 5.1: Medical Device Approval Process: US
  • Figure 5.2: Medical Device Approval Process: Canada
  • Figure 5.3: Regulatory Bodies in EU5 Countries
  • Figure 5.4: Medical Device Approval Process: Europe (CE Marking Process)
  • Figure 5.5: Medical Device Approval Process: Japan
  • Figure 5.6: Medical Device Approval Process: China
  • Figure 5.7: Medical Device Approval Process: South Africa
  • Figure 5.8: Multi-Dimensional Heat Map Analysis: Comparison of Regional Regulatory Control
  • Figure 5.9: Summary of Regulatory Control for Medical Devices: Regional Analysis
  • Figure 6.1: DePuy Synthes: Annual Revenues, FY 2014 - FY 2018 (USD Billion)
  • Figure 6.2: DePuy Synthes: Bone Cement Delivery Systems
  • Figure 6.3: Medtronic: Annual Revenues, FY 2013 - H1 FY 2019 (USD Billion)
  • Figure 6.4: Medtronic: Revenues by Business Segments, FY 2018 (USD Billion)
  • Figure 6.5: Medtronic: Bone Cement Delivery Systems
  • Figure 6.6: Merit Medical Systems: Annual Revenues, FY 2014 - FY 2018 (USD Billion)
  • Figure 6.7: Merit Medical Systems: Bone Cement Delivery Systems
  • Figure 6.8: Smith & Nephew: Annual Revenues, FY 2014 - FY 2018 (USD Billion)
  • Figure 6.9: Smith & Nephew: Bone Cement Delivery Systems
  • Figure 6.10: Stryker: Annual Revenues, FY 2014 - FY 2018 (USD Billion)
  • Figure 6.11: Stryker: Bone Cement Delivery Systems
  • Figure 6.12: Zimmer Biomet: Annual Revenues, FY 2014 - FY 2018 (USD Billion)
  • Figure 6.13: Zimmer Biomet: Bone Cement Delivery Systems
  • Figure 6.14: Biopsybell: Bone Cement Delivery Systems
  • Figure 6.15: iMedicom: Bone Cement Delivery Systems
  • Figure 6.16: IZI Medical Products: Bone Cement Delivery Systems
  • Figure 6.17: Spirit Spine: Bone Cement Delivery Systems
  • Figure 6.18: Synimed: Bone Cement Delivery Systems
  • Figure 7.1: Mergers and Acquisitions: Year-Wise Cumulative Trend, 2014-2018
  • Figure 7.2: Mergers and Acquisitions: Distribution by Type of Agreement
  • Figure 7.3: Mergers and Acquisitions: Distribution by Year and Amount of Acquisition (USD Millions)
  • Figure 7.4: Mergers and Acquisitions: Regional Distribution
  • Figure 7.5: Mergers and Acquisitions: Intercontinental and Intracontinental Agreements
  • Figure 7.6: Mergers and Acquisitions: Ownership Change Matrix
  • Figure 7.7: Mergers and Acquisitions: Most Active Acquirers in Terms of Number of Acquisitions
  • Figure 7.8: Mergers and Acquisitions: Key Growth Drivers
  • Figure 7.9: Valuation Analysis: Deal Multiples of Key Acquisitions
  • Figure 8.1: Patent Portfolio: Distribution by Type of Patent
  • Figure 8.2: Patent Portfolio: Cumulative Distribution by Publication Year, 1976-2018
  • Figure 8.3: Patent Portfolio: Distribution by Geographical Location
  • Figure 8.4: Patent Portfolio: Distribution by Type of Surgical Procedure
  • Figure 8.5: Patent Portfolio: Distribution by CPC Classification Symbols
  • Figure 8.6: Patent Portfolio: Emerging Focus Areas
  • Figure 8.7: Patent Portfolio: Distribution by Type of Industry
  • Figure 8.8: Patent Portfolio: Leading Industry Players in Terms of Number of Patents
  • Figure 8.9: Patent Portfolio: Leading Non-Industry Players in Terms of Number of Patents
  • Figure 8.10: Patent Portfolio (DePuy Synthes and Medtronic): Benchmarking by Patent Characteristics
  • Figure 8.11: Patent Portfolio (Leading Industry Players): Benchmarking by Patent Characteristics
  • Figure 8.12: Patent Portfolio: Distribution of Patents by Age, 1999 - 2018
  • Figure 8.13: Patent Portfolio: Categorizations based on Weighted Valuation Scores
  • Figure 8.14: Patent Portfolio: Valuation Analysis
  • Figure 8.15: Opportunity Analysis of Expired Patents: Top Patents in North America
  • Figure 8.16: Opportunity Analysis of Expired Patents: Top Patents in Europe
  • Figure 8.17: Opportunity Analysis of Expired Patents: Top Patents in Asia-Pacific and Rest of the World
  • Figure 9.1: Clinical Trial Analysis: Distribution by Trial Status
  • Figure 9.2: Clinical Trial Analysis: Cumulative Distribution of Trials by Registration Year, Pre-2010-2018
  • Figure 9.3: Clinical Trial Analysis: Distribution by Trial Phase
  • Figure 9.4: Clinical Trial Analysis: Distribution by Study Design
  • Figure 9.5: Clinical Trial Analysis: Analysis by Study Intervention
  • Figure 9.6: Clinical Trial Analysis: Analysis by Type of Surgical Procedure
  • Figure 9.7: Clinical Trial Analysis: Cumulative Distribution by Type of Surgical Procedure and Trial Registration Year
  • Figure 9.8: Clinical Trial Analysis: Geographical Distribution by Number of Trials
  • Figure 9.9: Clinical Trial Analysis: Geographical Distribution by Enrolled Patient Population
  • Figure 9.10: Clinical Trials Analysis: Cumulative Year-wise Trend by Trial Recruitment Status
  • Figure 9.11: Clinical Trial Analysis: Geographical Distribution by Trial Registration Year and Recruitment Status
  • Figure 9.12: Clinical Trial Analysis: Distribution by Type of Sponsors / Collaborators
  • Figure 9.13: Clinical Trial Analysis: Leading Industry Players in Terms of Number of Trials Conducted
  • Figure 9.14: Clinical Trial Analysis: Leading Non-Industry Players in Terms of Number of Trials Conducted
  • Figure 9.15: Clinical Trial Analysis: Focus Areas
  • Figure 9.16: Clinical Trial Analysis: Overview of Popular Keywords
  • Figure 9.17: Clinical Trial Analysis: Distribution by Clinical Trial End Points
  • Figure 10.1: Grant Analysis: Popular Keywords
  • Figure 10.2: Grant Analysis: Analysis by Emerging Focus Areas
  • Figure 10.3: Grant Analysis: Cumulative Trend by Year of Award, 2010-2018
  • Figure 10.4: Grant Analysis: Distribution by Support Period, 2010-2018
  • Figure 10.5: Grant Analysis: Cumulative Distribution of Amount Awarded by Year, 2010-2018 (USD Million)
  • Figure 10.6: Grant Analysis: Cumulative Distribution of Amount Awarded and Type of Surgical Procedure by Year, 2010-2018 (USD Million)
  • Figure 10.7: Grant Analysis: Distribution by Grant Type
  • Figure 10.8: Grant Analysis: Distribution by Grant Type and Type of Surgical Procedure
  • Figure 10.9: Grant Analysis: Distribution by Responsible Study Section
  • Figure 10.10: Grant Analysis: Distribution by Type of Bone Cement
  • Figure 11.1: Global Demand for Bone Cement Delivery Systems, 2019-2030 (Million Units)
  • Figure 11.2: Demand for Bone Cement Delivery Systems: Share by Type of Surgical Procedure, 2019 and 2030
  • Figure 11.3: Global Demand for Bone Cement Delivery Systems for Hip Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.4: Global Demand for Bone Cement Delivery Systems for Knee Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.5: Global Demand for Bone Cement Delivery Systems for Kyphoplasty, 2019-2030 (Million Units)
  • Figure 11.6: Global Demand for Bone Cement Delivery Systems for Vertebroplasty, 2019-2030 (Million Units)
  • Figure 11.7: Demand for Bone Cement Delivery Systems: Share by Geography, 2019 and 2030
  • Figure 11.8: Demand for Bone Cement Delivery Systems: Share by Geography and Type of Surgical Procedure, 2019
  • Figure 11.9: Demand for Bone Cement Delivery Systems in North America, 2019-2030 (Million Units)
  • Figure 11.10: Demand for Bone Cement Delivery Systems in the US, 2019-2030 (Million Units)
  • Figure 11.11: Demand for Bone Cement Delivery Systems in the US for Hip Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.12: Demand for Bone Cement Delivery Systems in the US for Knee Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.13: Demand for Bone Cement Delivery Systems in the US for Kyphoplasty, 2019-2030 (Thousand Units)
  • Figure 11.14: Demand for Bone Cement Delivery Systems in the US for Vertebroplasty, 2019-2030 (Thousand Units)
  • Figure 11.15: Demand for Bone Cement Delivery Systems in Canada, 2019-2030 (Million Units)
  • Figure 11.16: Demand for Bone Cement Delivery Systems in Canada for Hip Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.17: Demand for Bone Cement Delivery Systems in Canada for Knee Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.18: Demand for Bone Cement Delivery Systems in Canada for Kyphoplasty, 2019-2030 (Thousand Units)
  • Figure 11.19: Demand for Bone Cement Delivery Systems in Canada for Vertebroplasty, 2019-2030 (Thousand Units)
  • Figure 11.20: Demand for Bone Cement Delivery Systems in Mexico, 2019-2030 (Million Units)
  • Figure 11.21: Demand for Bone Cement Delivery Systems in Mexico for Hip Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.22: Demand for Bone Cement Delivery Systems in Mexico for Knee Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.23: Demand for Bone Cement Delivery Systems in Mexico for Kyphoplasty, 2019-2030 (Thousand Units)
  • Figure 11.24: Demand for Bone Cement Delivery Systems in Mexico for Vertebroplasty, 2019-2030 (Thousand Units)
  • Figure 11.25: Demand for Bone Cement Delivery Systems in Europe, 2019-2030 (Million Units)
  • Figure 11.26: Demand for Bone Cement Delivery Systems in France, 2019-2030 (Million Units)
  • Figure 11.27: Demand for Bone Cement Delivery Systems in France for Hip Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.28: Demand for Bone Cement Delivery Systems in France for Knee Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.29: Demand for Bone Cement Delivery Systems in France for Kyphoplasty, 2019-2030 (Thousand Units)
  • Figure 11.30: Demand for Bone Cement Delivery Systems in France for Vertebroplasty, 2019-2030 (Thousand Units)
  • Figure 11.31: Demand for Bone Cement Delivery Systems in Germany, 2019-2030 (Million Units)
  • Figure 11.32: Demand for Bone Cement Delivery Systems in Germany for Hip Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.33: Demand for Bone Cement Delivery Systems in Germany for Knee Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.34: Demand for Bone Cement Delivery Systems in Germany for Kyphoplasty, 2019-2030 (Thousand Units)
  • Figure 11.35: Demand for Bone Cement Delivery Systems in Germany for Vertebroplasty, 2019-2030 (Thousand Units)
  • Figure 11.36: Demand for Bone Cement Delivery Systems in Italy, 2019-2030 (Million Units)
  • Figure 11.37: Demand for Bone Cement Delivery Systems in Italy for Hip Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.38: Demand for Bone Cement Delivery Systems in Italy for Knee Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.39: Demand for Bone Cement Delivery Systems in Italy for Kyphoplasty, 2019-2030 (Thousand Units)
  • Figure 11.40: Demand for Bone Cement Delivery Systems in Italy for Vertebroplasty, 2019-2030 (Thousand Units)
  • Figure 11.41: Demand for Bone Cement Delivery Systems in Spain, 2019-2030 (Million Units)
  • Figure 11.42: Demand for Bone Cement Delivery Systems in Spain for Hip Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.43: Demand for Bone Cement Delivery Systems in Spain for Knee Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.44: Demand for Bone Cement Delivery Systems in Spain for Kyphoplasty, 2019-2030 (Thousand Units)
  • Figure 11.45: Demand for Bone Cement Delivery Systems in Spain for Vertebroplasty, 2019-2030 (Thousand Units)
  • Figure 11.46: Demand for Bone Cement Delivery Systems in the UK, 2019-2030 (Million Units)
  • Figure 11.47: Demand for Bone Cement Delivery Systems in the UK for Hip Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.48: Demand for Bone Cement Delivery Systems in the UK for Knee Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.49: Demand for Bone Cement Delivery Systems in the UK for Kyphoplasty, 2019-2030 (Thousand Units)
  • Figure 11.50: Demand for Bone Cement Delivery Systems in the UK for Vertebroplasty, 2019-2030 (Thousand Units)
  • Figure 11.51: Demand for Bone Cement Delivery Systems in Asia-Pacific and Rest of the World, 2019-2030 (Million Units)
  • Figure 11.52: Demand for Bone Cement Delivery Systems in Australia, 2019-2030 (Million Units)
  • Figure 11.53: Demand for Bone Cement Delivery Systems in Australia for Hip Arthroplasty, 2019-2030 (A
  • Figure 11.54: Demand for Bone Cement Delivery Systems in Australia for Knee Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.55: Demand for Bone Cement Delivery Systems in Australia for Kyphoplasty, 2019-2030 (Thousand Units)
  • Figure 11.56: Demand for Bone Cement Delivery Systems in Australia for Vertebroplasty, 2019-2030 (Thousand Units)
  • Figure 11.57: Demand for Bone Cement Delivery Systems in China, 2019-2030 (Million Units)
  • Figure 11.58: Demand for Bone Cement Delivery Systems in China for Hip Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.59: Demand for Bone Cement Delivery Systems in China for Knee Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.60: Demand for Bone Cement Delivery Systems in China for Kyphoplasty, 2019-2030 (Thousand Units)
  • Figure 11.61: Demand for Bone Cement Delivery Systems in China for Vertebroplasty, 2019-2030 (Thousand Units)
  • Figure 11.62: Demand for Bone Cement Delivery Systems in India, 2019-2030 (Million Units)
  • Figure 11.63: Demand for Bone Cement Delivery Systems in India for Hip Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.64: Demand for Bone Cement Delivery Systems in India for Knee Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.65: Demand for Bone Cement Delivery Systems in India for Kyphoplasty, 2019-2030 (Thousand Units)
  • Figure 11.66: Demand for Bone Cement Delivery Systems in India for Vertebroplasty, 2019-2030 (Thousand Units)
  • Figure 11.67: Demand for Bone Cement Delivery Systems in Japan, 2019-2030 (Million Units)
  • Figure 11.68: Demand for Bone Cement Delivery Systems in Japan for Hip Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.69: Demand for Bone Cement Delivery Systems in Japan for Knee Arthroplasty, 2019-2030 (Million Units)
  • Figure 11.70: Demand for Bone Cement Delivery Systems in Japan for Kyphoplasty, 2019-2030 (Thousand Units)
  • Figure 11.71: Demand for Bone Cement Delivery Systems in Japan for Vertebroplasty, 2019-2030 (Thousand Units)
  • Figure 11.72: Global Demand for Bone Cement Delivery Systems: Comparison across Different Surgical Procedures, 2019 and 2030
  • Figure 11.73: Global Demand for Bone Cement Delivery Systems: Comparison across Different Geographies, 2019 and 2030
  • Figure 12.1: Global Bone Cement Delivery Systems Market, 2019-2030 (USD Million)
  • Figure 12.2: Global Bone Cement Delivery Systems Market: Share by Type of Surgical Procedure, 2019 and 2030
  • Figure 12.3: Bone Cement Delivery Systems Market for Hip Arthroplasty, 2019-2030 (USD Million)
  • Figure 12.4: Bone Cement Delivery Systems Market for Knee Arthroplasty, 2019-2030 (USD Million)
  • Figure 12.5: Bone Cement Delivery Systems Market for Kyphoplasty, 2019-2030 (USD Million)
  • Figure 12.6: Bone Cement Delivery Systems Market for Vertebroplasty, 2019-2030 (USD Million)
  • Figure 12.7: Global Bone Cement Delivery Systems Market: Share by Type of End-Users, 2019 and 2030
  • Figure 12.8: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers, 2019-2030 (USD Million)
  • Figure 12.9: Bone Cement Delivery Systems Market for Hospitals, 2019-2030 (USD Million)
  • Figure 12.10: Bone Cement Delivery Systems Market for Specialty Clinics, 2019-2030 (USD Million)
  • Figure 12.11: Global Bone Cement Delivery Systems Market: Share by Geography, 2019 and 2030
  • Figure 12.12: Bone Cement Delivery Systems Market in North America, 2019-2030 (USD Million)
  • Figure 12.13: Bone Cement Delivery Systems Market in the US, 2019-2030 (USD Million)
  • Figure 12.14: Bone Cement Delivery Systems Market in Canada, 2019-2030 (USD Million)
  • Figure 12.15: Bone Cement Delivery Systems Market in Mexico, 2019-2030 (USD Million)
  • Figure 12.16: Bone Cement Delivery Systems Market in Europe, 2019-2030 (USD Million)
  • Figure 12.17: Bone Cement Delivery Systems Market in France, 2019-2030 (USD Million)
  • Figure 12.18: Bone Cement Delivery Systems Market in Germany, 2019-2030 (USD Million)
  • Figure 12.19: Bone Cement Delivery Systems Market in Italy, 2019-2030 (USD Million)
  • Figure 12.20: Bone Cement Delivery Systems Market in Spain, 2019-2030 (USD Million)
  • Figure 12.21: Bone Cement Delivery Systems Market in the UK, 2019-2030 (USD Million)
  • Figure 12.22: Bone Cement Delivery Systems Market in Asia-Pacific and Rest of the World, 2019-2030 (USD Million)
  • Figure 12.23: Bone Cement Delivery Systems Market in Australia, 2019-2030 (USD Million)
  • Figure 12.24: Bone Cement Delivery Systems Market in China, 2019-2030 (USD Million)
  • Figure 12.25: Bone Cement Delivery Systems Market in India, 2019-2030 (USD Million)
  • Figure 12.26: Bone Cement Delivery Systems Market in Japan, 2019-2030 (USD Million)
  • Figure 12.27: Bone Cement Delivery Systems Market for Hip Arthroplasty in North America, 2019-2030 (USD Million)
  • Figure 12.28: Bone Cement Delivery Systems Market for Hip Arthroplasty in the US, 2019-2030 (USD Million)
  • Figure 12.29: Bone Cement Delivery Systems Market for Hip Arthroplasty in Canada, 2019-2030 (USD Million)
  • Figure 12.30: Bone Cement Delivery Systems Market for Hip Arthroplasty in Mexico, 2019-2030 (USD Million)
  • Figure 12.31: Bone Cement Delivery Systems Market for Hip Arthroplasty in Europe, 2019-2030 (USD Million)
  • Figure 12.32: Bone Cement Delivery Systems Market for Hip Arthroplasty in France, 2019-2030 (USD Million)
  • Figure 12.33: Bone Cement Delivery Systems Market for Hip Arthroplasty in Germany, 2019-2030 (USD Million)
  • Figure 12.34: Bone Cement Delivery Systems Market for Hip Arthroplasty in Italy, 2019-2030 (USD Million)
  • Figure 12.35: Bone Cement Delivery Systems Market for Hip Arthroplasty in Spain, 2019-2030 (USD Million)
  • Figure 12.36: Bone Cement Delivery Systems Market for Hip Arthroplasty in the UK, 2019-2030 (USD Million)
  • Figure 12.37: Bone Cement Delivery Systems Market for Hip Arthroplasty in Asia-Pacific and Rest of the World, 2019-2030 (USD Million)
  • Figure 12.38: Bone Cement Delivery Systems Market for Hip Arthroplasty in Australia, 2019-2030 (USD Million)
  • Figure 12.39: Bone Cement Delivery Systems Market for Hip Arthroplasty in China, 2019-2030 (USD Million)
  • Figure 12.40: Bone Cement Delivery Systems Market for Hip Arthroplasty in India, 2019-2030 (USD Million)
  • Figure 12.41: Bone Cement Delivery Systems Market for Hip Arthroplasty in Japan, 2019-2030 (USD Million)
  • Figure 12.42: Bone Cement Delivery Systems Market for Knee Arthroplasty in North America, 2019-2030 (USD Million)
  • Figure 12.43: Bone Cement Delivery Systems Market for Knee Arthroplasty in the US, 2019-2030 (USD Million)
  • Figure 12.44: Bone Cement Delivery Systems Market for Knee Arthroplasty in Canada, 2019-2030 (USD Million)
  • Figure 12.45: Bone Cement Delivery Systems Market for Knee Arthroplasty in Mexico, 2019-2030 (USD Million)
  • Figure 12.46: Bone Cement Delivery Systems Market for Knee Arthroplasty in Europe, 2019-2030 (USD Million)
  • Figure 12.47: Bone Cement Delivery Systems Market for Knee Arthroplasty in France, 2019-2030 (USD Million)
  • Figure 12.48: Bone Cement Delivery Systems Market for Knee Arthroplasty in Germany, 2019-2030 (USD Million)
  • Figure 12.49: Bone Cement Delivery Systems Market for Knee Arthroplasty in Italy, 2019-2030 (USD Million)
  • Figure 12.50: Bone Cement Delivery Systems Market for Knee Arthroplasty in Spain, 2019-2030 (USD Million)
  • Figure 12.51: Bone Cement Delivery Systems Market for Knee Arthroplasty in the UK, 2019-2030 (USD Million)
  • Figure 12.52: Bone Cement Delivery Systems Market for Knee Arthroplasty in Asia-Pacific and Rest of the World, 2019-2030 (USD Million)
  • Figure 12.53: Bone Cement Delivery Systems Market for Knee Arthroplasty in Australia, 2019-2030 (USD Million)
  • Figure 12.54: Bone Cement Delivery Systems Market for Knee Arthroplasty in China, 2019-2030 (USD Million)
  • Figure 12.55: Bone Cement Delivery Systems Market for Knee Arthroplasty in India, 2019-2030 (USD Million)
  • Figure 12.56: Bone Cement Delivery Systems Market for Knee Arthroplasty in Japan, 2019-2030 (USD Million)
  • Figure 12.57: Bone Cement Delivery Systems Market for Kyphoplasty in North America, 2019-2030 (USD Million)
  • Figure 12.58: Bone Cement Delivery Systems Market for Kyphoplasty in the US, 2019-2030 (USD Million)
  • Figure 12.59: Bone Cement Delivery Systems Market for Kyphoplasty in Canada, 2019-2030 (USD Million)
  • Figure 12.60: Bone Cement Delivery Systems Market for Kyphoplasty in Mexico, 2019-2030 (USD Million)
  • Figure 12.61: Bone Cement Delivery Systems Market for Kyphoplasty in Europe, 2019-2030 (USD Million)
  • Figure 12.62: Bone Cement Delivery Systems Market for Kyphoplasty in France, 2019-2030 (USD Million)
  • Figure 12.63: Bone Cement Delivery Systems Market for Kyphoplasty in Germany, 2019-2030 (USD Million)
  • Figure 12.64: Bone Cement Delivery Systems Market for Kyphoplasty in Italy, 2019-2030 (USD Million)
  • Figure 12.65: Bone Cement Delivery Systems Market for Kyphoplasty in Spain, 2019-2030 (USD Million)
  • Figure 12.66: Bone Cement Delivery Systems Market for Kyphoplasty in the UK, 2019-2030 (USD Million)
  • Figure 12.67: Bone Cement Delivery Systems Market for Kyphoplasty in Asia-Pacific and Rest of the World, 2019-2030 (USD Million)
  • Figure 12.68: Bone Cement Delivery Systems Market for Kyphoplasty in Australia, 2019-2030 (USD Million)
  • Figure 12.69: Bone Cement Delivery Systems Market for Kyphoplasty in China, 2019-2030 (USD Million)
  • Figure 12.70: Bone Cement Delivery Systems Market for Kyphoplasty in India, 2019-2030 (USD Million)
  • Figure 12.71: Bone Cement Delivery Systems Market for Kyphoplasty in Japan, 2019-2030 (USD Million)
  • Figure 12.72: Bone Cement Delivery Systems Market for Vertebroplasty in North America, 2019-2030 (USD Million)
  • Figure 12.73: Bone Cement Delivery Systems Market for Vertebroplasty in the US, 2019-2030 (USD Million)
  • Figure 12.74: Bone Cement Delivery Systems Market for Vertebroplasty in Canada, 2019-2030 (USD Million)
  • Figure 12.75: Bone Cement Delivery Systems Market for Vertebroplasty in Mexico, 2019-2030 (USD Million)
  • Figure 12.76: Bone Cement Delivery Systems Market for Vertebroplasty in Europe, 2019-2030 (USD Million)
  • Figure 12.77: Bone Cement Delivery Systems Market for Vertebroplasty in France, 2019-2030 (USD Million)
  • Figure 12.78: Bone Cement Delivery Systems Market for Vertebroplasty in Germany, 2019-2030 (USD Million)
  • Figure 12.79: Bone Cement Delivery Systems Market for Vertebroplasty in Italy, 2019-2030 (USD Million)
  • Figure 12.80: Bone Cement Delivery Systems Market for Vertebroplasty in Spain, 2019-2030 (USD Million)
  • Figure 12.81: Bone Cement Delivery Systems Market for Vertebroplasty in the UK, 2019-2030 (USD Million)
  • Figure 12.82: Bone Cement Delivery Systems Market for Vertebroplasty in Asia-Pacific and Rest of the World, 2019-2030 (USD Million)
  • Figure 12.83: Bone Cement Delivery Systems Market for Vertebroplasty in Australia, 2019-2030 (USD Million)
  • Figure 12.84: Bone Cement Delivery Systems Market for Vertebroplasty in China, 2019-2030 (USD Million)
  • Figure 12.85: Bone Cement Delivery Systems Market for Vertebroplasty in India, 2019-2030 (USD Million)
  • Figure 12.86: Bone Cement Delivery Systems Market for Vertebroplasty in Japan, 2019-2030 (USD Million)
  • Figure 12.87: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in North America, 2019-2030 (USD Million)
  • Figure 12.88: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in the US, 2019-2030 (USD Million)
  • Figure 12.89: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Canada, 2019-2030 (USD Million)
  • Figure 12.90: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Mexico, 2019-2030 (USD Million)
  • Figure 12.91: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Europe, 2019-2030 (USD Million)
  • Figure 12.92: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in France, 2019-2030 (USD Million)
  • Figure 12.93: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Germany, 2019-2030 (USD Million)
  • Figure 12.94: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Italy, 2019-2030 (USD Million)
  • Figure 12.95: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Spain, 2019-2030 (USD Million)
  • Figure 12.96: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in the UK, 2019-2030 (USD Million)
  • Figure 12.97: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Asia-Pacific and Rest of the World, 2019-2030 (USD Million)
  • Figure 12.98: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Australia, 2019-2030 (USD Million)
  • Figure 12.99: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in China, 2019-2030 (USD Million)
  • Figure 12.100: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in India, 2019-2030 (USD Million)
  • Figure 12.101: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Japan, 2019-2030 (USD Million)
  • Figure 12.102: Bone Cement Delivery Systems Market for Hospitals in North America, 2019-2030 (USD Million)
  • Figure 12.103: Bone Cement Delivery Systems Market for Hospitals in the US, 2019-2030 (USD Million)
  • Figure 12.104: Bone Cement Delivery Systems Market for Hospitals in Canada, 2019-2030 (USD Million)
  • Figure 12.105: Bone Cement Delivery Systems Market for Hospitals in Mexico, 2019-2030 (USD Million)
  • Figure 12.106: Bone Cement Delivery Systems Market for Hospitals in Europe, 2019-2030 (USD Million)
  • Figure 12.107: Bone Cement Delivery Systems Market for Hospitals in France, 2019-2030 (USD Million)
  • Figure 12.108: Bone Cement Delivery Systems Market for Hospitals in Germany, 2019-2030 (USD Million)
  • Figure 12.109: Bone Cement Delivery Systems Market for Hospitals in Italy, 2019-2030 (USD Million)
  • Figure 12.110: Bone Cement Delivery Systems Market for Hospitals in Spain, 2019-2030 (USD Million)
  • Figure 12.111: Bone Cement Delivery Systems Market for Hospitals in the UK, 2019-2030 (USD Million)
  • Figure 12.112: Bone Cement Delivery Systems Market for Hospitals in Asia-Pacific and Rest of the World, 2019-2030 (USD Million)
  • Figure 12.113: Bone Cement Delivery Systems Market for Hospitals in Australia, 2019-2030 (USD Million)
  • Figure 12.114: Bone Cement Delivery Systems Market for Hospitals in China, 2019-2030 (USD Million)
  • Figure 12.115: Bone Cement Delivery Systems Market for Hospitals in India, 2019-2030 (USD Million)
  • Figure 12.116: Bone Cement Delivery Systems Market for Hospitals in Japan, 2019-2030 (USD Million)
  • Figure 12.117: Bone Cement Delivery Systems Market for Specialty Clinics in North America, 2019-2030 (USD Million)
  • Figure 12.118: Bone Cement Delivery Systems Market for Specialty Clinics in the US, 2019-2030 (USD Million)
  • Figure 12.119: Bone Cement Delivery Systems Market for Specialty Clinics in Canada, 2019-2030 (USD Million)
  • Figure 12.120: Bone Cement Delivery Systems Market for Specialty Clinics in Mexico, 2019-2030 (USD Million)
  • Figure 12.121: Bone Cement Delivery Systems Market for Specialty Clinics in Europe, 2019-2030 (USD Million)
  • Figure 12.122: Bone Cement Delivery Systems Market for Specialty Clinics in France, 2019-2030 (USD Million)
  • Figure 12.123: Bone Cement Delivery Systems Market for Specialty Clinics in Germany, 2019-2030 (USD Million)
  • Figure 12.124: Bone Cement Delivery Systems Market for Specialty Clinics in Italy, 2019-2030 (USD Million)
  • Figure 12.125: Bone Cement Delivery Systems Market for Specialty Clinics in Spain, 2019-2030 (USD Million)
  • Figure 12.126: Bone Cement Delivery Systems Market for Specialty Clinics in the UK, 2019-2030 (USD Million)
  • Figure 12.127: Bone Cement Delivery Systems Market for Specialty Clinics in Asia-Pacific and Rest of the World, 2019-2030 (USD Million)
  • Figure 12.128: Bone Cement Delivery Systems Market for Specialty Clinics in Australia, 2019-2030 (USD Million)
  • Figure 12.129: Bone Cement Delivery Systems Market for Specialty Clinics in China, 2019-2030 (USD Million)
  • Figure 12.130: Bone Cement Delivery Systems Market for Specialty Clinics in India, 2019-2030 (USD Million)
  • Figure 12.131: Bone Cement Delivery Systems Market for Specialty Clinics in Japan, 2019-2030 (USD Million)
  • Figure 13.1: Overall Bone Cement Delivery Systems Market: Conservative, Base and Optimistic Scenario, 2019, 2024 and 2030 (USD Billion)

List of Tables

  • Table 3.1: Composition of Commercially Available Bone Cements
  • Table 4.1: List of Bone Cement Delivery Systems
  • Table 4.2: Bone Cement Delivery Systems: Information on Type of Surgical Procedure
  • Table 4.3: Bone Cement Delivery Systems: Information on Type of Bone Cement
  • Table 4.4: Bone Cement Delivery Systems: Information on Viscosity of Bone Cement
  • Table 4.5: Bone Cement Delivery Systems: Information on Approval Year
  • Table 4.6: Bone Cement Delivery Systems: Information on Key System Specifications
  • Table 4.7: Bone Cement Delivery Systems: Information on Developers
  • Table 4.8: List of Bone Cement Mixer Systems
  • Table 5.1: Device Classification: US
  • Table 5.2: Device Classification: Canada
  • Table 5.3: Device Classification: Europe
  • Table 5.4: List of CE Directives in Europe
  • Table 5.5: Conformity Assessment Modules in Europe
  • Table 5.6: Device Classification: Japan
  • Table 5.7: Device Classification: China
  • Table 5.8: Device Classification: South Africa
  • Table 6.1: one Cement Delivery Systems: List of Companies Profiled
  • Table 6.2: DePuy Synthes: Key Highlights
  • Table 6.3: DePuy Synthes: Key Characteristics of CONFIDENCE SPINAL CEMENT SYSTEM®
  • Table 6.4: DePuy Synthes: Key Characteristics of Device B
  • Table 6.5: DePuy Synthes: Key Characteristics of Device C
  • Table 6.6: DePuy Synthes: Key Characteristics of Device D
  • Table 6.7: DePuy Synthes: Key Characteristics of Device E
  • Table 6.8: DePuy Synthes: Key Characteristics of Device F
  • Table 6.9: DePuy Synthes: Key Characteristics of Device G
  • Table 6.10: DePuy Synthes: Recent Developments and Future Outlook
  • Table 6.11: Medtronic: Key Highlights
  • Table 6.12: Medtronic: Key Characteristics of Confidence Bone Cement Delivery System - Fenestrated Introducer Needle
  • Table 6.13: Medtronic: Key Characteristics of Device B
  • Table 6.14: Medtronic: Key Characteristics of Device C
  • Table 6.15: Medtronic: Key Characteristics of Device D
  • Table 6.16: Medtronic: Recent Developments and Future Outlook
  • Table 6.17: Merit Medical Systems: Key Highlights
  • Table 6.18: Merit Medical Systems: Key Characteristics of Osseoflex CD-H Hydraulic Cement Delivery System
  • Table 6.19: Merit Medical Systems: Key Characteristics of Device B
  • Table 6.20: Merit Medical Systems: Key Characteristics of Device C
  • Table 6.21: Merit Medical Systems: Key Characteristics of Device D
  • Table 6.22: Merit Medical Systems: Key Characteristics of Device E
  • Table 6.23: Merit Medical Systems: Recent Developments and Future Outlook
  • Table 6.24: Smith & Nephew: Key Highlights
  • Table 6.25: Smith & Nephew: Key Characteristics of EZ flow ™ Cement Delivery System
  • Table 6.26: Smith & Nephew: Key Characteristics of Device B
  • Table 6.27: Smith & Nephew: Key Characteristics of Device C
  • Table 6.28: Smith & Nephew: Key Characteristics of Device D
  • Table 6.29: Smith & Nephew: Recent Developments and Future Outlook
  • Table 6.30: Stryker: Key Highlights
  • Table 6.31: Stryker: Key Characteristics of ALIQUOT™ Delivery System
  • Table 6.32: Stryker: Key Characteristics of Device B
  • Table 6.33: Stryker: Key Characteristics of Device C
  • Table 6.34: Stryker: Key Characteristics of Device D
  • Table 6.35: Stryker: Key Characteristics of Device E
  • Table 6.36: Stryker: Key Characteristics of Device F
  • Table 6.37: Stryker: Key Characteristics of Device G
  • Table 6.38: Stryker: Key Characteristics of Device H
  • Table 6.39: Stryker: Key Characteristics of Device I
  • Table 6.40: Stryker: Key Characteristics of Device J
  • Table 6.41: Stryker: Recent Developments and Future Outlook
  • Table 6.42: Zimmer Biomet: Key Highlights
  • Table 6.43: Zimmer Biomet: Key Characteristics of ClearMix™ Vacuum Mixing and Delivery System
  • Table 6.44: Zimmer Biomet: Key Characteristics of Device B
  • Table 6.45: Zimmer Biomet: Key Characteristics of Device C
  • Table 6.46: Zimmer Biomet: Recent Developments and Future Outlook
  • Table 6.47: Biopsybell: Company Profile
  • Table 6.48: Biopsybell: Key Characteristics of Easynject Bone Cement Delivery System
  • Table 6.49: Biopsybell: Key Characteristics of Device B
  • Table 6.50: Biopsybell: Key Characteristics of Device C
  • Table 6.51: iMedicom: Company Profile
  • Table 6.52: iMedicom: Key Characteristics of MEDINAUT™-X IBE System
  • Table 6.53: iMedicom: Key Characteristics of Device B
  • Table 6.54: iMedicom: Key Characteristics of Device C
  • Table 6.55: IZI Medical Products: Company Profile
  • Table 6.56: IZI Medical Products: Key Characteristics of Blazer-C Vertebral Augmentation System
  • Table 6.57: IZI Medical Products: Key Characteristics of Device B
  • Table 6.58: IZI Medical Products: Key Characteristics of Device C
  • Table 6.59: IZI Medical Products: Key Characteristics of Device D
  • Table 6.60: Spirit Spine: Company Profile
  • Table 6.61: Spirit Spine: Key Characteristics of Controllable Cement Delivery System
  • Table 6.62: Spirit Spine: Key Characteristics of Device B
  • Table 6.63: Spirit Spine: Key Characteristics of Device C
  • Table 6.64: Spirit Spine: Key Characteristics of Device D
  • Table 6.65: Synimed: Company Profile
  • Table 6.66: Synimed: Key Characteristics of APV Synicem Vertebroplasty System
  • Table 6.67: Synimed: Key Characteristics of Device B
  • Table 6.68: Synimed: Key Characteristics of Device C
  • Table 6.69: Synimed: Key Characteristics of Device D
  • Table 7.1: Bone Cement Delivery Systems: List of Mergers and Acquisitions
  • Table 7.2: Bone Cement Delivery Systems: Information on Key Value Drivers of Acquisitions
  • Table 7.3: Key Acquisitions: Deal Multiples (Based on Company Revenue, Company Size and Experience)
  • Table 8.1: Patent Portfolio: CPC Classification Symbol Definitions
  • Table 8.2: Patent Portfolio: Most Popular CPC Classification Symbols
  • Table 8.3: Patent Portfolio: List of Top CPC Classifications
  • Table 8.4: Patent Portfolio: List of Leading Individual Assignees
  • Table 8.5: Patent Portfolio: Summary of Benchmarking Analysis
  • Table 8.6: Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
  • Table 10.1: List of Grants: Information on Project Title and Goal, 2010-2018
  • Table 10.2: List of Grants: Information on Type of Surgical Procedure, Cement Type and Amount Awarded, 2010-2018
  • Table 15.1: Bone Cement Delivery Systems: Distribution by System Functionality
  • Table 15.2: Bone Cement Delivery Systems: Distribution by Type of Surgical Procedure
  • Table 15.3: Bone Cement Delivery Systems: Distribution by Type of Bone Cement
  • Table 15.4: Bone Cement Delivery Systems: Distribution by Viscosity of Bone Cement
  • Table 15.5: Bone Cement Delivery Systems: Distribution by Type and Viscosity of Bone Cement
  • Table 15.6: Bone Cement Delivery Systems: Distribution by Type of Surgical Procedure and Viscosity of Bone Cement
  • Table 15.7: Bone Cement Delivery Systems: Distribution by Approval Year
  • Table 15.8: Bone Cement Delivery System Developers: Distribution of Developers by Year of Establishment
  • Table 15.9: Bone Cement Delivery System Developers: Distribution of Developers by Location of Headquarters
  • Table 15.10: Bone Cement Delivery System Developers: Distribution of Developers by Size of Company
  • Table 15.11: Leading Developers: Distribution by Number of Devices
  • Table 15.12: Developer Landscape: Analysis by Company Size and Location of Headquarters
  • Table 15.13: DePuy Synthes: Annual Revenues, FY 2014 - FY 2018 (USD Billion)
  • Table 15.14: Medtronic: Annual Revenues, FY 2013 - H1 FY 2019 (USD Billion)
  • Table 15.15: Medtronic: Revenues by Business Segments, FY 2018 (USD Billion)
  • Table 15.16: Merit Medical Systems: Annual Revenues, FY 2014 - FY 2018 (USD Billion)
  • Table 15.17: Smith & Nephew: Annual Revenues, FY 2014 - FY 2018 (USD Billion)
  • Table 15.18: Stryker: Annual Revenues, FY 2014 - FY 2018 (USD Billion)
  • Table 15.19: Zimmer Biomet: Annual Revenues, FY 2014 - FY 2018 (USD Billion)
  • Table 15.20: Mergers and Acquisitions: Year-Wise Cumulative Trend (2014-2018)
  • Table 15.21: Mergers and Acquisitions: Distribution by Type of Agreement (2014-2018)
  • Table 15.22: Mergers and Acquisitions: Distribution by Year and Amount of Acquisitions (USD Millions)
  • Table 15.23: Mergers and Acquisitions: Regional Distribution
  • Table 15.24: Mergers and Acquisitions: Intercontinental and Intracontinental Agreements
  • Table 15.25: Mergers and Acquisitions: Ownership Matrix
  • Table 15.26: Mergers and Acquisitions: Most Active Acquirers in Terms of Number of Acquisitions
  • Table 15.27: Mergers and Acquisitions: Key Growth Drivers
  • Table 15.28: Patent Portfolio: Distribution by Type of Patent
  • Table 15.29: Patent Portfolio: Cumulative Distribution by Publication Year, 1976-2018
  • Table 15.30: Patent Portfolio: Distribution by Geographical Location
  • Table 15.31: Patent Portfolio: Distribution by Type of Surgical Procedure
  • Table 15.32: Patent Portfolio: Distribution by Type of Industry
  • Table 15.33: Patent Portfolio: Distribution by Leading Industry Players in Terms of Number of Patents
  • Table 15.34: Patent Portfolio: Distribution by Leading Non-Industry Players in Terms of Number of Patents
  • Table 15.35: Patent Portfolio: Distribution of Patents by Age (1999 - 2018)
  • Table 15.36: Patent Portfolio: Categorizations based on Weighted Valuation Scores
  • Table 15.37: Clinical Trial Analysis: Distribution by Trial Status
  • Table 15.38: Clinical Trial Analysis: Cumulative Distribution of Trials by Registration Year, Pre-2010-2018
  • Table 15.39: Clinical Trial Analysis: Distribution by Trial Phase
  • Table 15.40: Clinical Trial Analysis: Distribution by Study Design
  • Table 15.41: Clinical Trial Analysis: Analysis by Study Intervention
  • Table 15.42: Clinical Trial Analysis: Analysis by Type of Surgical Procedure
  • Table 15.43: Clinical Trial Analysis: Cumulative Year-wise Trend of Trial Recruitment Status
  • Table 15.44: Clinical Trial Analysis: Distribution by Type of Sponsors / Collaborators
  • Table 15.45: Clinical Trial Analysis: Popular Industry Players in Terms of Number of Trials Conducted
  • Table 15.46: Clinical Trial Analysis: Popular Non-Industry Players in Terms of Number of Trials Conducted
  • Table 15.47: Clinical Trial Analysis: Overview of Popular Keywords
  • Table 15.48: Grant Analysis: Analysis by Emerging Focus Areas
  • Table 15.49: Grant Analysis: Cumulative Trend by Year of Award, 2010-2018
  • Table 15.50: Grant Analysis: Distribution by Support Period, 2010-2018
  • Table 15.51: Grant Analysis: Cumulative Distribution of Amount Awarded by Year, 2010-2018 (USD Million)
  • Table 15.52: Grant Analysis: Cumulative Distribution of Amount Awarded and Type of Surgical Procedure by Year, 2010-2018 (USD Million)
  • Table 15.53: Grant Analysis: Distribution by Grant Type
  • Table 15.54: Grant Analysis: Distribution by Grant Type and Type of Surgical Procedure
  • Table 15.55: Grant Analysis: Distribution by Responsible Study Selection
  • Table 15.56: Grant Analysis: Distribution by Type of Bone Cement
  • Table 15.57: Global Demand for Bone Cement Delivery Systems, 2019-2030 (Million Units)
  • Table 15.58: Demand for Bone Cement Delivery Systems: Share by Type of Surgical Procedure, 2019 and 2030
  • Table 15.59: Global Demand for Bone Cement Delivery Systems for Hip Arthroplasty, 2019-2030 (Million Units)
  • Table 15.60: Global Demand for Bone Cement Delivery Systems for Knee Arthroplasty, 2019-2030 (Million Units)
  • Table 15.61: Global Demand for Bone Cement Delivery Systems for Kyphoplasty, 2019-2030 (Million Units)
  • Table 15.62: Global Demand for Bone Cement Delivery Systems for Vertebroplasty, 2019-2030 (Million Units)
  • Table 15.63: Demand for Bone Cement Delivery Systems: Share by Geography, 2019 and 2030
  • Table 15.64: Demand for Bone Cement Delivery Systems in North America, 2019-2030 (Million Units)
  • Table 15.65: Demand for Bone Cement Delivery Systems in US, 2019-2030 (Million Units)
  • Table 15.66: Demand for Bone Cement Delivery Systems in US for Hip Arthroplasty, 2019-2030 (Million Units)
  • Table 15.67: Demand for Bone Cement Delivery Systems in US for Knee Arthroplasty, 2019-2030 (Million Units)
  • Table 15.68: Demand for Bone Cement Delivery Systems in US for Kyphoplasty, 2019-2030 (Thousand Units)
  • Table 15.69: Demand for Bone Cement Delivery Systems in US for Vertebroplasty, 2019-2030 (Thousand Units)
  • Table 15.70: Demand for Bone Cement Delivery Systems in Canada, 2019-2030 (Million Units)
  • Table 15.71: Demand for Bone Cement Delivery Systems in Canada for Knee Arthroplasty, 2019-2030 (Million Units)
  • Table 15.72: Demand for Bone Cement Delivery Systems in Canada for Kyphoplasty, 2019-2030 (Thousand Units)
  • Table 15.73: Demand for Bone Cement Delivery Systems in Canada for Vertebroplasty, 2019-2030 (Thousand Units)
  • Table 15.74: Demand for Bone Cement Delivery Systems in Mexico, 2019-2030 (Million Units)
  • Table 15.75: Demand for Bone Cement Delivery Systems in Mexico for Hip Arthroplasty, 2019-2030 (Million Units)
  • Table 15.76: Demand for Bone Cement Delivery Systems in Mexico for Knee Arthroplasty, 2019-2030 (Million Units)
  • Table 15.77: Demand for Bone Cement Delivery Systems in Mexico for Kyphoplasty, 2019-2030 (Thousand Units)
  • Table 15.78: Demand for Bone Cement Delivery Systems in Mexico for Vertebroplasty, 2019-2030 (Thousand Units)
  • Table 15.79: Demand for Bone Cement Delivery Systems in Europe, 2019-2030 (Million Units)
  • Table 15.80: Demand for Bone Cement Delivery Systems in France, 2019-2030 (Million Units)
  • Table 15.81: Demand for Bone Cement Delivery Systems in France for Hip Arthroplasty, 2019-2030 (Million Units)
  • Table 15.82: Demand for Bone Cement Delivery Systems in France for Knee Arthroplasty, 2019-2030 (Million Units)
  • Table 15.83: Demand for Bone Cement Delivery Systems in France for Kyphoplasty, 2019-2030 (Thousand Units)
  • Table 15.84: Demand for Bone Cement Delivery Systems in France for Vertebroplasty, 2019-2030 (Thousand Units)
  • Table 15.85: Demand for Bone Cement Delivery Systems in Germany, 2019-2030 (Million Units)
  • Table 15.86: Demand for Bone Cement Delivery Systems in Germany for Hip Arthroplasty, 2019-2030 (Million Units)
  • Table 15.87: Demand for Bone Cement Delivery Systems in Germany for Knee Arthroplasty, 2019-2030 (Million Units)
  • Table 15.88: Demand for Bone Cement Delivery Systems in Germany for Kyphoplasty, 2019-2030 (Thousand Units)
  • Table 15.89: Demand for Bone Cement Delivery Systems in Germany for Vertebroplasty, 2019-2030 (Thousand Units)
  • Table 15.90: Demand for Bone Cement Delivery Systems in Italy, 2019-2030 (Million Units)
  • Table 15.91: Demand for Bone Cement Delivery Systems in Italy for Hip Arthroplasty, 2019-2030 (Million Units)
  • Table 15.92: Demand for Bone Cement Delivery Systems in Italy for Knee Arthroplasty, 2019-2030 (Million Units)
  • Table 15.93: Demand for Bone Cement Delivery Systems in Italy for Kyphoplasty, 2019-2030 (Thousand Units)
  • Table 15.94: Demand for Bone Cement Delivery Systems in Italy for Vertebroplasty, 2019-2030 (Thousand Units)
  • Table 15.95: Demand for Bone Cement Delivery Systems in Spain, 2019-2030 (Million Units)
  • Table 15.96: Demand for Bone Cement Delivery Systems in Spain for Hip Arthroplasty, 2019-2030 (Million Units)
  • Table 15.97: Demand for Bone Cement Delivery Systems in Spain for Knee Arthroplasty, 2019-2030 (Million Units)
  • Table 15.98: Demand for Bone Cement Delivery Systems in Spain for Kyphoplasty, 2019-2030 (Thousand Units)
  • Table 15.99: Demand for Bone Cement Delivery Systems in Spain for Vertebroplasty, 2019-2030 (Thousand Units)
  • Table 15.100: Demand for Bone Cement Delivery Systems in the UK, 2019-2030 (Million Units)
  • Table 15.101: Demand for Bone Cement Delivery Systems in the UK for Hip Arthroplasty, 2019-2030 (Million Units)
  • Table 15.102: Demand for Bone Cement Delivery Systems in the UK for Knee Arthroplasty, 2019-2030 (Million Units)
  • Table 15.103: Demand for Bone Cement Delivery Systems in the UK for Kyphoplasty, 2019-2030 (Thousand Units)
  • Table 15.104: Demand for Bone Cement Delivery Systems in The UK for Vertebroplasty, 2019-2030 (Thousand Units)
  • Table 15.105: Demand for Bone Cement Delivery Systems in Asia-Pacific and Rest of the World, 2019-2030 (Million Units)
  • Table 15.106: Demand for Bone Cement Delivery Systems in Australia, 2019-2030 (Million Units)
  • Table 15.107: Demand for Bone Cement Delivery Systems in Australia for Hip Arthroplasty, 2019-2030
  • Table 15.108: Demand for Bone Cement Delivery Systems in Australia for Knee Arthroplasty, 2019-2030 (Million Units)
  • Table 15.109: Demand for Bone Cement Delivery Systems in Australia for Kyphoplasty, 2019-2030 (Thousand Units)
  • Table 15.110: Demand for Bone Cement Delivery Systems in Australia for Vertebroplasty, 2019-2030 (Thousand Units)
  • Table 15.111: Demand for Bone Cement Delivery Systems in China, 2019-2030 (Million Units)
  • Table 15.112: Demand for Bone Cement Delivery Systems in China for Hip Arthroplasty, 2019-2030 (Million Units)
  • Table 15.113: Demand for Bone Cement Delivery Systems in China for Knee Arthroplasty, 2019-2030 (Million Units)
  • Table 15.114: Demand for Bone Cement Delivery Systems in China for Kyphoplasty, 2019-2030 (Thousand Units)
  • Table 15.115: Demand for Bone Cement Delivery Systems in China for Vertebroplasty, 2019-2030 (Thousand Units)
  • Table 15.116: Demand for Bone Cement Delivery Systems in India, 2019-2030 (Million Units)
  • Table 15.117: Demand for Bone Cement Delivery Systems in India for Hip Arthroplasty, 2019-2030 (Million Units)
  • Table 15.118: Demand for Bone Cement Delivery Systems in India for Knee Arthroplasty, 2019-2030 (Million Units)
  • Table 15.119: Demand for Bone Cement Delivery Systems in India for Kyphoplasty, 2019-2030 (Thousand Units)
  • Table 15.120: Demand for Bone Cement Delivery Systems in India for Vertebroplasty, 2019-2030 (Thousand Units)
  • Table 15.121: Demand for Bone Cement Delivery Systems in Japan, 2019-2030 (Million Units)
  • Table 15.122: Demand for Bone Cement Delivery Systems in Japan for Hip Arthroplasty, 2019-2030 (Million Units)
  • Table 15.123: Demand for Bone Cement Delivery Systems in Japan for Knee Arthroplasty, 2019-2030 (Million Units)
  • Table 15.124: Demand for Bone Cement Delivery Systems in Japan for Kyphoplasty, 2019-2030 (Thousand Units)
  • Table 15.125: Demand for Bone Cement Delivery Systems in Japan for Vertebroplasty, 2019-2030 (Thousand Units)
  • Table 15.126: Global Demand for Bone Cement Delivery Systems: Comparison across Different Surgical Procedures, 2019 and 2030
  • Table 15.127: Global Bone Cement Delivery Systems Market, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.128: Global Bone Cement Delivery Systems Market: Share by Type of Surgical Procedure, 2019 and 2030
  • Table 15.129: Bone Cement Delivery Systems Market for Hip Arthroplasty, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.130: Bone Cement Delivery Systems Market for Knee Arthroplasty, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.131: Bone Cement Delivery Systems Market for Kyphoplasty, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.132: Bone Cement Delivery Systems Market for Vertebroplasty, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.133: Global Bone Cement Delivery Systems Market: Share by Type of End-Users, 2019 and 2030
  • Table 15.134: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.135: Bone Cement Delivery Systems Market for Hospitals, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.136: Bone Cement Delivery Systems Market for Specialty Clinics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.137: Global Bone Cement Delivery Systems Market: Share by Geography, 2019 and 2030
  • Table 15.138: Bone Cement Delivery Systems Market in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.139: Bone Cement Delivery Systems Market in the US, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.140: Bone Cement Delivery Systems Market in Canada, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.141: Bone Cement Delivery Systems Market in Mexico, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.142: Bone Cement Delivery Systems Market in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.143: Bone Cement Delivery Systems Market in France, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.144: Bone Cement Delivery Systems Market in Germany, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.145: Bone Cement Delivery Systems Market in Italy, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.146: Bone Cement Delivery Systems Market in Spain, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.147: Bone Cement Delivery Systems Market in the UK, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.148: Bone Cement Delivery Systems Market in Asia-Pacific and Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.149: Bone Cement Delivery Systems Market in Australia, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.150: Bone Cement Delivery Systems Market in China, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.151: Bone Cement Delivery Systems Market in India, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.152: Bone Cement Delivery Systems Market in Japan, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.153: Bone Cement Delivery Systems Market for Hip Arthroplasty in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.154: Bone Cement Delivery Systems Market for Hip Arthroplasty in the US, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.155: Bone Cement Delivery Systems Market for Hip Arthroplasty in Canada, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.156: Bone Cement Delivery Systems Market for Hip Arthroplasty in Mexico, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.157: Bone Cement Delivery Systems Market for Hip Arthroplasty in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.158: Bone Cement Delivery Systems Market for Hip Arthroplasty in France, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.159: Bone Cement Delivery Systems Market for Hip Arthroplasty in Germany, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.160: Bone Cement Delivery Systems Market for Hip Arthroplasty in Italy, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.161: Bone Cement Delivery Systems Market for Hip Arthroplasty in Spain, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.162: Bone Cement Delivery Systems Market for Hip Arthroplasty in the UK, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.163: Bone Cement Delivery Systems Market for Hip Arthroplasty in Asia-Pacific and Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.164: Bone Cement Delivery Systems Market for Hip Arthroplasty in Australia, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.165: Bone Cement Delivery Systems Market for Hip Arthroplasty in China, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.166: Bone Cement Delivery Systems Market for Hip Arthroplasty in India, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.167: Bone Cement Delivery Systems Market for Hip Arthroplasty in Japan, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.168: Bone Cement Delivery Systems Market for Knee Arthroplasty in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.169: Bone Cement Delivery Systems Market for Knee Arthroplasty in the US, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.170: Bone Cement Delivery Systems Market for Knee Arthroplasty in Canada, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.171: Bone Cement Delivery Systems Market for Knee Arthroplasty in Mexico, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.172: Bone Cement Delivery Systems Market for Knee Arthroplasty in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.173: Bone Cement Delivery Systems Market for Knee Arthroplasty in France, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.174: Bone Cement Delivery Systems Market for Knee Arthroplasty in Germany, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.175: Bone Cement Delivery Systems Market for Knee Arthroplasty in Italy, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.176: Bone Cement Delivery Systems Market for Knee Arthroplasty in Spain, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.177: Bone Cement Delivery Systems Market for Knee Arthroplasty in the UK, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.178: Bone Cement Delivery Systems Market for Knee Arthroplasty in Asia-Pacific and Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.179: Bone Cement Delivery Systems Market for Knee Arthroplasty in Australia, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.180: Bone Cement Delivery Systems Market for Knee Arthroplasty in China, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.181: Bone Cement Delivery Systems Market for Knee Arthroplasty in India, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.182: Bone Cement Delivery Systems Market for Knee Arthroplasty in Japan, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.183: Bone Cement Delivery Systems Market for Kyphoplasty in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.184: Bone Cement Delivery Systems Market for Kyphoplasty in the US, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.185: Bone Cement Delivery Systems Market for Kyphoplasty in Canada, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.186: Bone Cement Delivery Systems Market for Kyphoplasty in Mexico, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.187: Bone Cement Delivery Systems Market for Kyphoplasty in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.188: Bone Cement Delivery Systems Market for Kyphoplasty in France, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.189: Bone Cement Delivery Systems Market for Kyphoplasty in Germany, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.190: Bone Cement Delivery Systems Market for Kyphoplasty in Italy, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.191: Bone Cement Delivery Systems Market for Kyphoplasty in Spain, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.192: Bone Cement Delivery Systems Market for Kyphoplasty in the UK, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.193: Bone Cement Delivery Systems Market for Kyphoplasty in Asia-Pacific and Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.194: Bone Cement Delivery Systems Market for Kyphoplasty in Australia, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.195: Bone Cement Delivery Systems Market for Kyphoplasty in China, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.196: Bone Cement Delivery Systems Market for Kyphoplasty in India, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.197: Bone Cement Delivery Systems Market for Kyphoplasty in Japan, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.198: Bone Cement Delivery Systems Market for Vertebroplasty in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.199: Bone Cement Delivery Systems Market for Vertebroplasty in the US, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.200: Bone Cement Delivery Systems Market for Vertebroplasty in Canada, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.201: Bone Cement Delivery Systems Market for Vertebroplasty in Mexico, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.202: Bone Cement Delivery Systems Market for Vertebroplasty in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.203: Bone Cement Delivery Systems Market for Vertebroplasty in France, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.204: Bone Cement Delivery Systems Market for Vertebroplasty in Germany, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.205: Bone Cement Delivery Systems Market for Vertebroplasty in Italy, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.206: Bone Cement Delivery Systems Market for Vertebroplasty in Spain, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.207: Bone Cement Delivery Systems Market for Vertebroplasty in the UK, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.208: Bone Cement Delivery Systems Market for Vertebroplasty in Asia-Pacific and Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.209: Bone Cement Delivery Systems Market for Vertebroplasty in Australia, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.210: Bone Cement Delivery Systems Market for Vertebroplasty in China, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.211: Bone Cement Delivery Systems Market for Vertebroplasty in India, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.212: Bone Cement Delivery Systems Market for Vertebroplasty in Japan, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.213: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.214: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in the US, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.215: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Canada, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.216: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Mexico, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.217: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.218: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in France, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.219: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Germany, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.220: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Italy, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.221: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Spain, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.222: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in the UK, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.223: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Asia-Pacific and Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.224: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Australia, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.225: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in China, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.226: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in India, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.227: Bone Cement Delivery Systems Market for Ambulatory Surgery Centers in Japan, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.228: Bone Cement Delivery Systems Market for Hospitals in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.229: Bone Cement Delivery Systems Market for Hospitals in the US, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.230: Bone Cement Delivery Systems Market for Hospitals in Canada, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.231: Bone Cement Delivery Systems Market for Hospitals in Mexico, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.232: Bone Cement Delivery Systems Market for Hospitals in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.233: Bone Cement Delivery Systems Market for Hospitals in France, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.234: Bone Cement Delivery Systems Market for Hospitals in Germany, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.235: Bone Cement Delivery Systems Market for Hospitals in Italy, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.236: Bone Cement Delivery Systems Market for Hospitals in Spain, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.237: Bone Cement Delivery Systems Market for Hospitals in the UK, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.238: Bone Cement Delivery Systems Market for Hospitals in Asia-Pacific and Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.239: Bone Cement Delivery Systems Market for Hospitals in Australia, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.240: Bone Cement Delivery Systems Market for Hospitals in China, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.241: Bone Cement Delivery Systems Market for Hospitals in India, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.242: Bone Cement Delivery Systems Market for Hospitals in Japan, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.243: Bone Cement Delivery Systems Market for Specialty Clinics in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.244: Bone Cement Delivery Systems Market for Specialty Clinics in the US, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.245: Bone Cement Delivery Systems Market for Specialty Clinics in Canada, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.246: Bone Cement Delivery Systems Market for Specialty Clinics in Mexico, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.247: Bone Cement Delivery Systems Market for Specialty Clinics in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.248: Bone Cement Delivery Systems Market for Specialty Clinics in France, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.249: Bone Cement Delivery Systems Market for Specialty Clinics in Germany, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.250: Bone Cement Delivery Systems Market for Specialty Clinics in Italy, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.251: Bone Cement Delivery Systems Market for Specialty Clinics in Spain, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.252: Bone Cement Delivery Systems Market for Specialty Clinics in the UK, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.253: Bone Cement Delivery Systems Market for Specialty Clinics in Asia-Pacific and Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.254: Bone Cement Delivery Systems Market for Specialty Clinics in Australia, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.255: Bone Cement Delivery Systems Market for Specialty Clinics in China, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.256: Bone Cement Delivery Systems Market for Specialty Clinics in India, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.257: Bone Cement Delivery Systems Market for Specialty Clinics in Japan, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)

Listed Companies:

The following companies / institutes / government bodies and organizations have been mentioned in this report.

  • 3M
  • aap Implantate
  • Aarhus University
  • Artech
  • AB Medical Technologies
  • Aetna
  • Affinergy
  • Airlangga University
  • Alphatec Spine
  • American Academy of Orthopedic Surgeon
  • American Well
  • Apple
  • Argon Medical Devices
  • Arthrex
  • Armstrong Medical
  • ArthroCare
  • Arthrosurface
  • Ascendx Spine
  • Atlas General Hospital
  • AxioMed
  • Baxter
  • Bayer
  • Becton Dickinson
  • Benvenue Medical
  • Beth Israel Deaconess Medical Center
  • Biomet
  • Biopsybell
  • Blue Belt Technologies
  • BM Korea
  • BSN medical
  • Cairo University
  • Cardinal Health
  • CareFusion
  • Catheter Connections
  • Cayenne Medical
  • CD Diagnostics
  • Centers for Disease Control and Prevention
  • Ceterix Orthopaedics
  • Chicago State University
  • Cianna Medical
  • Clean Medical
  • Compression Therapy Concepts
  • ConforMIS
  • Cook Medical
  • Crosstrees Medical
  • Danderyds Hospital
  • DePuy Synthes
  • DFINE
  • Disc-O-Tech Medical Technologies
  • DJO Global
  • EARTH MEDISYS
  • Edge Medical
  • Elite Surgical
  • Entellus Medical
  • Ethicon
  • Eurociencia Colombia
  • Ewha Womans University
  • Exactech
  • Excelsius Surgical
  • Faith In Practice
  • Fitbit
  • Fluidic Tools
  • G-21
  • Globus Medical
  • Heraeus Medical
  • HyperBranch Medical Technology
  • IMEDICOM
  • Imperial College London
  • Indo UK Institute of Health
  • Institute for Public Health Surveillance
  • Instratek
  • Invuity
  • IZI Medical Products
  • Johns Hopkins University
  • Johnson & Johnson
  • JointPoint
  • JPMorgan Chase
  • K2M Group Holdings
  • Kyungwon Medical
  • LANDAUER
  • Launchpad Medical
  • Lawson Health Research Institute
  • LDR Holding
  • Leaf Healthcare
  • Lehigh Valley Health Network
  • Leiden University Medical Center
  • Lund University
  • Mayo Clinic
  • Mazor Robotics
  • McGill University
  • Medacta International
  • Medical Enterprises Distribution
  • MEDMIX SYSTEMS
  • MedTech
  • Medtronic
  • Mercy
  • Merit Medical Systems
  • Meta Biomed
  • MHT Group
  • MolecuLight
  • Morgan Steer Orthopaedics
  • Nanova
  • National Health Service
  • National Institutes of Health
  • National Science Foundation
  • Nemaris
  • Nihon Americare
  • NinePoint Medical
  • Nordson MEDICAL
  • Novadaq Technologies
  • Nutrino Health
  • Olympus
  • optimed
  • Oregon Surgical Institute
  • Ortho Development
  • Ortho Transmission
  • OrthoD Group
  • Orthofix International
  • OSARTIS
  • OsteoRemedies
  • Paradigm Pharmaceuticals
  • Perfect Medicare
  • PIOLAX Medical Devices
  • Pivot Medical
  • Prosidyan
  • Public Assistance - Paris Hospital
  • PUSM Medical Device
  • Regent Surgical Health
  • Rice University
  • RODO Medical
  • Rotation Medical
  • Rush University Medical Center
  • Rushford Hypersonic
  • Rutgers University
  • Safe Orthopaedics
  • SafeOp Surgical
  • Saytek Medikal Sistemler
  • Sentio
  • Shanghai Kinetic Medical
  • Sintea Plustek
  • Skeletal Kinetics
  • Small Bone Innovations
  • Smith & Nephew
  • SOMATEX Medical Technologies
  • Sonoran Biosciences
  • Spine Wave
  • Spine Align
  • Spirit Spine
  • Stanford University
  • Stanmore Implants Worldwide
  • STERYLAB
  • Stockli Medical
  • Stryker
  • Suzhou AND Science & Technology Development
  • Synimed
  • Taeyeon Medical
  • Tecres
  • Thiebaud Biomedical Devices
  • ThompsonMIS
  • Troy Polymers
  • University of California
  • University of Connecticut
  • University of Hull
  • University of Iowa
  • University of Lisbon
  • University of Maryland
  • University of Pennsylvania
  • University of Texas
  • University of Toledo
  • University of Zurich
  • Upstate Medical University
  • Vanderbilt University
  • Vanderbilt University Medical Center
  • Vascular Insights
  • Warsaw Orthopedic
  • Wellframe
  • West End Surgical
  • World Health Organization
  • Yale University
Back to Top